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Abstract 
ABSTRACT 
Cell transplantation on biodegradable scaffolds is an established approach in 
tissue engineering to the problem of the regeneration of diseased or damaged 
tissues. As cells grow and organise themselves, they secrete their own 
extracellular matrix, while the polymer degrades into natural metabolites 
resulting in eventual natural tissue replacement. Polymeric materials used for 
these scaffolds must satisfy a number of requirements. These include defined 
cell-interactive properties, porosity, biodegradability, mechanical and 
controlled release properties. 
To date, scaffolds have been designed to conform to these requirements. 
However, the need to preform defined three-dimensional structures requires 
prior knowledge of the dimensions of the defect or cavity to be filled. 
Furthermore the general use of toxic solvents in the processing of these 
scaffolds prevents the incorporation of biological agents and cells during 
fabrication. Therefore, poor transportation of cells through the scaffolds can 
result in low cell seeding efficiencies. Finally such scaffolds require an 
invasive operation for transplantation of the material. 
In contrast a number of injectable materials have been proposed and 
investigated. The transformation from liquid pre-cursor to gel in such systems 
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can, however, require cell harmful trigger signals such as UV exposure or pH 
changes. Furthermore, these injectable gels lack a porous structure preventing 
effective cell migration and restricting tissue formation and vascularisation to 
the barrier of diffusion for signalling and nutrient molecules. 
The work in this thesis presents a scaffold that is both injectable and conforms 
to the requirements of water-insoluble porous scaffolds. This starts with the 
synthesis of a biotinylated poly (lactic acid)-poly (ethylene glycol) (PLA-PEG) 
copolymer. The polymer is degradable, protein resistant and cell interactive 
when used in conjunction with biotinylated cell adhesive peptides. The biotin 
unit tethered to the PEG-PLA also provides the polymer with self-assembling 
properties when used in conjunction with avidin. 
In contrast to alternative injectable materials, the scaffold presented in this 
thesis is porous. This porosity is necessary for tissue ingrowth and 
vascularization. Therefore, before progressing on to the manufacture of the 
scaffold, a systematic study of two cell types involved in vascularisation was 
carried out over defined pore features. These studies revealed that cell 
behaviour over pore features was related to cell type, cell density and pore size. 
This had significant implications for the injectable scaffold in development 
because proposed advantages were delivery of a variety of cell types, 
controlled porous structure, and efficient cell seeding. 
Microparticles were then manufactured from the PLA-PEG-biotin using a 
single emulsion manufacturing process. Surface Plasmon Resonance (SPR) 
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confirmed that these microparticles would bind efficiently to avidin. The 
condition for optimum self-assembling of particles was then determined using 
aggregation studies. These studies showed that a critical quantity of avidin was 
required for microparticles to aggregate together. The ability to aggregate 
particles of different sizes leads to the potential for controlling scaffold 
porosity. Rheological testing showed that the scaffold's mechanical properties 
could be tailored to that of the tissue in which regeneration is required. 
The self-assembly of microparticles was also demonstrated to form complex 
three-dimensional scaffolds without the use of toxic solvents. Scaffolds 
prepared in simulated tissues maintained shape upon injection. Scaffolds were 
then self-assembled with cells entrapped within them. Cell viability within the 
self-assembling scaffolds was confirmed by Alamar Blue assays. In vivo 
studies have demonstrated that cell-scaffold composites permit tissue ingrowth 
and thus readily undergo vascularisation. 
The novel molecular-interaction mechanism of self-assembly of these scaffolds 
differentiates this material from other injectable systems. The formation of 
porous scaffolds within a cavity or a soft-tissue could be a pre-requisite for 
tissue remodelling using new cell sources that are dependent on vascularization 
and tissue ingrowth. The basic component of the scaffold is a biodegradable 
microparticle that presents a protein resistant surface with biotinylated 
moieties. Therefore, standard controlled release technologies and biotin-avidin 
mediated surface engineering can be combined with the self-assembly to form 
biomimetic scaffolds that stimulate integrin-mediated cell adhesion and then 
release growth factors. 
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Chapter 1: Introduction 
CHAPTER 1 
INTRODUCTION 
1.1 Tissue Engineering 
Tissue engineering is an interdisciplinary field that applies the principles of 
engineering and the biological sciences to offer the possibility to create 
completely natural tissue and replace failing or malfunctioning organs (Langer 
and Vacanti 1993). 
There are inherent difficulties in current organ and tissue transplantations 
strategies because donor shortages have resulted in a significant number of 
patients on the waiting list for operations. This list has increased from 19,095 
patients in 1989, to 74,800 by February 2001 in the USA alone (Stock and 
Vacanti 2001; Vacanti 2001). Furthermore, those patients fortunate enough to 
receive transplantations are subjected to immunosuppresion therapies for the 
rest of their lives because of the associated risks of infection and tumor 
development. The lack of donor tissue availability and donor site morbidity 
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further hampers transplantation of tissues. Replacement with mechanical 
devices is limited by an increased risk of inflammation and infection. 
Mechanical devices also lack the mechanism for self-repair and such devices 
will not grow concurrently with the patient (Vacanti and Langer 1999; Vacanti 
and Vacanti 2000; Vacanti 2001). 
The potential impact of tissue engineering from both a therapeutic and an 
economic standpoint is enormous. Organ failures and diseases are increasing 
with human life expectation. The total health care costs for patients suffering 
from tissue loss or organ failure exceed $400 billion annually in the USA 
alone. It has been estimated that the total market for tissue-engineered products 
in the USA will be $80 billion annually (Peppas and Langer 1994; Davis and 
Vacanti 1996). The success of alternative donor sources from other species like 
the pig still remain in doubt, because of potential transferable diseases such as 
the pig endogenous retrovirus (Stock and Vacanti 2001). 
The object of tissue engineering is to regenerate natural tissues from living 
cells to replace defective or lost tissues and organs. It involves the creation of 
natural tissue by transplanting cells removed from the patient or a close relative 
and seeded into an implant which serves as both an adhesive substrate and a 
physical support for the isolated cells. Using cells from the same genotype 
avoids many of the problems associated with immune rejection of foreign 
tissue. As these cells are capable of proliferation, a small number of harvested 
cells can be expanded until a cell mass sufficient to replace the organ function 
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is achieved. Therefore, it is not required to sacrifice the entire organ of the 
donor (Cima et al. 1991) (Vacanti et al. 1994). 
Tissue engineering can be classified into two main areas: in vivo and in vitro 
tissue engineering. Once a tissue can be generated on a large scale in vitro, it 
can then become a viable supply of new tissue for patients. In vitro tissue 
engineering thus requires a specifically designed environment for regeneration. 
This is in contrast to the in vivo approach, where most of the materials 
necessary for tissue regeneration are automatically provided by the host living 
body. To date, it has only been possible to proliferate singular cell types in 
vitro and thus the formation of only simple avascular structures is possible. 
Therefore, in vitro tissue engineering, whilst theoretically desirable, is 
currently limited to tissues such as dermis, epidermis and articular cartilage 
(Eaglstein and Falanga 1998; Christenson 1999; Edelman 1999; Atala and 
Nyberg 2000). 
Tissue regeneration in vivo attempts to achieve natural regeneration of tissues 
and organs by harnessing the natural healing process of the body. For large 
defects, it is necessary to use a scaffold as support for the tissue to grow. The 
scaffold may be used either with or without cell seeding prior to implantation. 
Scaffolds without cells just serve to imitate the natural extra-cellular matrix 
(ECM) of the body. Tissue regeneration is, in this case, dependent on the 
ingrowth from the surrounding tissue in a process, which is known as tissue 
induction. Vascularisation of a scaffold is a typical example of tissue induction 
(Mikos et al. 1993). 
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Tissues engineering using scaffolds with cells have been studied to restore the 
function of several tissues such as liver (Moghe 1996), blood vessels (Niklason 
and Langer 1997), nerve (Bellamkonda and Aebischer 1994), skin (Pachence 
1996), cartilage (LeBaron and Athanasiou 2000) and bone (Hutmacher 2000). 
Significant challenges to this approach include the design and fabrication of a 
suitable scaffold able to promote cell adhesion and to support cell growth, 
proliferation and differentiation and induced formation of natural tissue. In 
many cases, biocompatible, biodegradable polymers are utilised to either 
induce surrounding tissue and cell ingrowth or to serve as a temporary scaffold 
for transplanted cells to attach, grow, and maintain differentiated functions 
(Christenson et al. 1997). 
The original hypothesis that cells on polymer scaffolds could give rise to 
organised tissue extended from the following biological observations: 
1. Most tissues undergo constant remodelling (Healy et al. 1996). 
2. Dissociated mature cells can reorganise themselves into their native 
histological structures when placed in ideal cell culture conditions 
(Marler et al. 1998). 
3. While isolated cell populations are capable of histological 
reorganisation, this is limited when they are delivered as a cell 
suspension because they lack a template to guide restructuring (Kim 
and Mooney 1998). 
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4. The quantity of tissue for implantation is restricted by diffusion 
requirements for gas and nutrient exchange (Marler et al. 1998). 
The strategy of tissue engineering generally involves the following steps 
(Figure 1.1): Depending on the target organ, a suitable cell source is identified, 
isolated, and produced in sufficient numbers (Bonassar and Vacanti 1998; 
Stock and Vacanti 2001). Then a biocompatible material that can be used as a 
cell substrate or cell-encapsulation material is isolated or synthesised and 
processed into the required shape (Cima et al. 1991). The material is seeded 
uniformly with cells, which can then be grown in a bioreactor (Burg et al. 
2000) and finally the material-cell construct is placed into the target in vivo 
site, where depending on the site and the structure, vascularization may be 
necessary (Kim and Mooney 1998). 
1.2 Polymer Scaffolds 
A key element in a number of tissue engineering approaches is the use of a 
polymer scaffold (Vacanti et al. 1994). Isolated cells injected into the body at 
random cannot form new tissue on their own (Cima et al. 1991; Marler et al. 
1998). They require a specific environment in which a supporting material acts 
as a template for the in vitro cell seeding and the subsequent re-implantation 
into the host with the aim of tissue formation. Using a degradable scaffold on 
which cells grow and organize themselves can potentially achieve this. 
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lp. 
ý Biodegradable 
'olymer scaffold 
Cells seeded onto scaffold. As cells produce 
extracellular matrix and proliferate, synthetic 
polymer scaffold degrades 
In Vitro Tissue 
Engineering 
Grow tissue 
in bioreactor 
In Vivo Tissue 
ngineering 
Figure 1.1 Schematic representation of a typical tissue engineering approach. 
Specific cell populations are harvested from the appropriate tissue and seeded 
onto a biodegradable polymer scaffold. 
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As the cells begin to secrete their own extracellular matrix, the polymer 
degrades and is eventually eliminated from the body, resulting in completely 
natural tissue replacement (Peter et al. 1998). 
The work in this thesis presents the development of a novel in situ solidifying 
porous scaffold for tissue engineering. The review in this chapter will thus 
attempt to introduce the materials commonly used for scaffolds in tissue 
engineering, the design criteria of scaffolds in tissue engineering and the 
methods that are currently established for manufacturing porous scaffolds. 
1.2.1 Materials for scaffolds in tissue engineering 
The first step in the design of a scaffold for cell transplantation is the choice of 
a suitable material. The material must be biocompatible and preferably 
biodegradable to avoid the risk of complications that may be associated with 
the long-term presence of a foreign material in the body. Over the last century, 
materials such as metals, ceramics and polymers have been extensively used 
for surgical implantations (Kohn 1996). Metals and ceramics have contributed 
to major advances in the medical field, particularly in orthopaedic tissue 
replacement (Agrawal 1998). These materials, in comparison to polymers, 
however are difficult to process and lack biodegradability. The use of polymers 
can be sub-divided into two categories: natural polymers and synthetic 
polymers. 
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1.2.1.1 Natural derived polymers 
Proteins and sugars derived from natural extracellular matrices, such as 
collagen and glycosaminoglycan, have been used to repair nerve (Labrador et 
al. 1998), skin (Pachence 1996), cartilage (LeBaron and Athanasiou 2000) and 
bone (Winn et al. 1999). Chemical crosslinking by glutaraldehyde has been 
proposed to control the stability and degradation rate of these matrices, 
whereas porosity has been controlled using both chemical and physical 
techniques (Cavallaro and Kemp 1994). However, collagenous scaffolds that 
have been crosslinked with glutaraldehyde can exhibit immunogenicity, 
calcification and fibrous scarring during long term implantation (Cima et al. 
1991). 
Transplantation scaffolds fabricated from natural polymers can suffer from 
some major disadvantages such as poor mechanical performances. Collagen, 
hyaluronate, fibrin and gelatin, for an example lack mechanical strength. They 
can also provoke adverse tissue reactions and immune responses and they may 
promote undesired cell behaviour (Cima et al. 1991; Moghe 1996). However, 
numerous natural materials have found wide use in tissue engineering 
applications. Chitosan is a natural polysaccharide, whose structural 
characteristics are similar to glycosaminoglycans. Chitosan is highly soluble in 
an acidic environment and insoluble under neutral conditions. It has been used 
in a variety of biomedical applications, such as haemodialysis membranes, 
drug delivery systems, artificial skin, orthopaedic and dental coating materials 
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(Chuang et al. 1999; Chenite et al. 2000; Park et al. 2000). Alginates are also 
water-soluble polysaccharides which have the ability to form crosslinked gels 
in the presence of multivalent ions thus providing potential for a number of 
applications in drug delivery and tissue engineering (Rowley, 1999). Alginate 
is widely available (isolated from seaweed), has low diffusional barriers for 
nutrients and reasonable biocompatibility. However, the calcium ions on which 
gelation is dependent can be lost in the body (Kim and Mooney 1998). 
1.2.1.2 Synthetic polymers. 
There is a wide variety of synthetic polymers that have been investigated for 
biomaterial and tissue engineering applications. Poly (vinyl alcohol) (PVA), 
poly (N-isopropyacrylamide) (PNIPAAm) and its derivatives have for 
example, been shown to have great potential as delivery vehicles for cartilage 
and the pancreas. The non-degradable crosslinks and toxic crosslinking 
molecules used with polymers such as PNIPAAm are however drawbacks in 
the use of these materials (Li et al. 1998; Lee and Mooney 2001; Peng and 
Cheng 2001). 
The use of biodegradable materials has proven to be immensely important in 
medical applications over the last three decades. Polymers prepared from 
glycolic acid and lactic acid have found a multitude of uses in the medical 
industry, beginning with the biodegradable sutures first approved in the 1960s 
(Cima et al. 1991). 
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Since that time, diverse products based on lactic and glycolic acid and on other 
materials such as poly (c-caprolactone) homopolymers and copolymers have 
been accepted for use as medical devices (Yin and Baker 1999; Ural et al. 
2000). Table 1.1 describes the properties of some of these common 
biodegradable polymers. In addition to these approved materials, a great deal 
of research continues on polyanhydrides (Burkoth and Anseth 2000), 
polyorthoesters (Heller 1994), polyphosphazenes (Schacht et al. 1996) and 
other biodegradable polymers (Peppas and Langer 1994). 
The degradation mechanism varies with each of these polymer types. For 
example, polyorthoesters are surface eroding, whilst polyphosphazenes 
degradation rate can be controlled by changes in the structure of the side-chain 
rather than the backbone as with the polyesters. 
The molecular properties of an increasing number of synthetic polymers such 
as molecular weight, molecular weight distribution, composition and molecular 
architecture can be manipulated to modify their physico-mechanical properties 
(Gopferich 1996). Given the high processing ability for synthetic polymers, it 
is thus possible to have porous materials with well-controlled microstructure 
and good mechanical properties (Lu and Mikos 1996). 
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Polymer Melting point 
(°C) 
Glass- 
Transition 
Temp (°C) 
Modulus 
(Gpa) 
Degradation 
Time 
(months) 
PGA 225-230 35-40 7.0 6 to 12 
PLLA 173-178 60-65 2.7 >24 
PDLLA Amorphous 55-60 1.9 12 to 16 
PCL 58-63 (-65)-(-60) 0.4 >24 
PDO N/A (-10)-0 1.5 6 to 12 
PGA-TMC N/A N/A 2.4 6 to 12 
85/15 Amorphous 50-55 2.0 5 to 6 
PDLLG 
75/25 Amorphous 50-55 2.0 4 to 5 
PDLLG 
60/35 Amorphous 45-50 2.0 3 to 4 
PDLLG 
50/50 Amorphous 45-50 2.0 1 to 2 
PDLLG 
Table 1.1 Properties of common biodegradable polymers. 
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1.2.1.3 Poly a-hydroxy acids 
An important class of synthetic biodegradable polymers includes polyesters 
and copolyesters of lactic and glycolic acid (Figure 1.2) (Peter et al. 1998). 
They are among the few synthetic polymeric materials approved for human 
clinical use by the Food and Drug Administration (F. D. A. ). 
Due to their high versatility, the aliphatic polyesters derived from lactic acid 
and glycolic acid are the synthetic biodegradable polymers most commonly 
employed in medical and pharmaceutical applications including surgical 
sutures (Matsusue et al. 1992), drug delivery systems (Hubbell 1998), 
orthopaedic and reconstructive implants. These polymers are furthermore 
widely tested as biodegradable matrices to be used in transplantation of a 
variety of cells, such as osteoblasts (Ishaug-Riley et al. 1998), chondrocytes 
and hepatocytes (Kaufmann et al. 1997). 
Extensive research has been carried out to assess the regenerative potentials of 
different organs using porous biodegradable polyester materials as scaffolds for 
cell transplantation (Freed et al. 1994). 
Poly (lactic acids) can be prepared by two different routes: firstly, by 
polycondensation of lactic acid and secondly by ring-opening polymerisation 
of the cyclic dimer. Depending on the initiator, the polymerisation of lactide 
may follow three different reaction mechanisms: 
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Figure 1.2 Poly (lactic acid) (PLA) and poly (glycolic acid) (PGA) structures 
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1. A cationic mechanism 
2. An anionic mechanism 
3. An insertion mechanism (Kricheldorf and KreiserSaunders 1996) 
Cationic polymerisation has very few initiators and the products are of low 
molecular weight. C13 nuclear magnetic resonance spectroscopy (13C NMR) 
also showed that the polymers of lactide and glycolide produced were not truly 
random copolymers (Kricheldorf and Kreiser 1987). 
With anionic polymerisation of L-lactide there is a 10-20% racemization 
observed suggesting that chain-transfer reactions with the monomer via 
deprotonation takes place (Kricheldorf and Boettcher 1993). High molecular 
weights can only be obtained by a combination of butyl lithium (BuLi) and 
crown ethers, however lithium is a toxic material (Kricheldorf and 
KreiserSaunders 1996). 
One of the best methods for polymerisation of lactides is the insertion 
mechanism using stannous 2-ethylhexanoate (Sn(Oct)2) (Kricheldorf and 
KreiserSaunders 1996; Li et al. 1996). Sn(Oct)2 is a permitted food additive in 
numerous countries, which means that its toxicity is extremely low compared 
to other heavy metal salts. Sn(Oct)2 is also highly efficient and allows almost 
complete conversion even at monomer/catalyst ratios as high as 104: 1 
(Kricheldorf et al. 1995). Random copolymers are possible and the risk of 
racemization is low. This has been confirmed by work done to gain 
information on monomer sequences by 13C NMR on PLGA polymers prepared 
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using Sn(Oct)2 (Kricheldorf et al. 1985). Furthermore, when the polymerisation 
of L-lactide was catalysed with Sn(Oct)2 in the presence or absence of alcohol, 
the molecular weights parallel the lactide/alcohol ratio, but never the lactide/Sn 
ratio. Polymerisations conducted at low lactide/catalyst ratios in the absence of 
an alcohol yield poly (lactic acids) with a low content of 2-ethylhexanoate end- 
groups. Proton nuclear magnetic resonance spectroscopy ('H NMR) of 
chloroform (CHC13) solutions also demonstrated that Sn(Oct)2 forms stronger 
complexes with alcohol and weaker complexes with lactide. The reaction 
between lactide and hydroxyl (OH) end-groups is bound by an Sn atom via two 
sp3d2 orbitals (Figure 1.3) (Kricheldorf et al. 1995). 
The racemic poly (DL-lactic acid) (PDLLA) is amorphous and has a lower 
glass transition point than the two stereoregular polymers, poly (D-lactic acid) 
(PDLA) and poly (L-lactic acid) (PLLA). 
The copolymers of lactide and glycolide are less crystalline than the two 
homopolymers of the two monomers. Poly (lactic acid), because of the methyl 
group is more hydrophobic than the poly (glycolic acid) and water uptake 
increases as the glycolide ratio in the copolymer increases. 
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Figure 1.3 Stannous octoate and its complexation with the hydroxyl group to 
ring-open lactide(Kricheldorf et al. 1995) 
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The general crystallisation behaviour of poly (L-lactic acid) has been 
characterised and the equilibrium melting point and the glass transition 
temperature were found to be 215°C and 55°C respectively (Kalb and Pennings 
1980). The in vivo and in vitro degradation of PLLA occurs through hydrolytic 
degradation (Figure 1.4) (Lu et al. 2000). This is controlled not only by the 
water diffusion within the polymer matrix, but also by the release of the water- 
soluble acid oligomeric by-products. Consequently, the degradation profile is 
found to be dependent on a number of parameters, such as porosity, size and 
shape of the device. (Holy et al. 1999) 
In addition to the degradation rate, copolymerisation of lactides also has 
decisive effects on mechanical strength, hydrophilicity and biocompatibility of 
the final biomaterial. For example, biodegradable poly (ethylene glycol)/poly 
(lactic acid) block copolymers, covering a wide range of compositions and 
molecular weight have been synthesised. This copolymerisation is an easy way 
to modulate the hydrophilic/hydrophobic balance (Penco et al. 1996). 
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Figure 1.4 The degradation of poly (lactic acid) (Lunt 1998) 
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1.2.1.4 Poly (ethylene glycol) based copolymers. 
The inclusion of PEG in copolymer systems imparts beneficial surface 
properties within the body when scaffolds are manufactured from the polymer, 
because of the ability of PEG to repel proteins within aqueous environments 
(Holmberg et al. 1997). This property is a result of the hydrophilic nature of 
the PEG, which binds water through hydrogen bonding, which then prevents 
protein binding. This repulsion inhibits the adsorption of proteins to the 
polymer/scaffold surface and, therefore, prevents many undesirable polymer- 
cell interactions (Holmberg et al. 1997; Deible et al. 1998). For an example, in 
comparison to PLA, nanoparticles made from the PLA-PEG copolymer have 
increased blood circulation times and been demonstrated to be inert toward 
proteins of the coagulation system (Uhrich et al. 1999). 
Various methods have been used to achieve materials with a PEG surface. 
These include covalent grafting of PEG, which present reactive chain-ends at 
the surface (Otsuka et al. 1998), entrapment of PEG onto the surface (Quirk et 
A 2000), graft copolymerisation of PEG macro-monomer onto the surface 
(Rashkov et al. 1996), and direct adsorption of PEG onto surfaces in the form 
of a surfactant or a block copolymer in which one of the blocks is a PEG. 
Adsorption of amphiphilic PEG-containing block copolymers on the surface 
allows temporary passivation of the surfaces towards cell and protein 
adsorption, but such coatings are not stable and the density of PEG achievable 
on the surface is typically lower than that required for complete passivation. 
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Furthermore, most of the PEG coated surfaces possess no reactive group on the 
PEG chain end (Tziampazis et al. 2000; Veronese 2001). 
Heterobifunctional PEG has different functional groups at both chain ends. 
When one of the functional end-groups in the heterobifunctional PEG 
selectivity initiates the polymerization of a hydrophobic monomer, a new 
heterobifunctional AB block copolymer can be prepared, keeping the other 
functional group at the PEG chain end available (Otsuka et al. 1998). Poly a- 
hydroxy acids such as PLA are ideal as the hydrophobic segment of PEG based 
copolymers because the Food and Drug Administration (FDA) approve both 
PEG and PLA for medical/clinical use. PLA-PEG copolymer systems possess 
surfactant properties because the PEG block is very hydrophilic and the PLA 
block is hydrophobic (Zhu et al. 1990). Therefore, when PLA-PEG is 
employed in a fabrication process that uses an aqueous external phase, e. g., 
particle fabrication by the single emulsion technique, PEG enriches the surface 
(Hrkach et al. 1997). This process is described in more detail in Chapter 5. 
There are a variety of techniques by which PLGA-PEG and PLA-PEG 
copolymers can be synthesised. These vary from the most common method of 
reacting lactide/glycolide monomers with the hydroxy-terminated groups of 
PEG using stannous chloride (Deng et al. 1990), aluminium tri-isopropoxide 
(Li and Kissel 1993), isobutylaluminoxane (Chen et al. 1997), and stannous 
octoate (Sn(Oct)2) (Kricheldorf and Meierhaack 1993; Kricheldorf et al. 1995; 
Li et al. 1996) to chain extension reactions on PLGA thermal oligomers by a 
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polycondensation reaction using a, w-bis-hydroxylated oligomers, such as 
polyethyleneglycols. (Penco et al. 1998) 
A difficulty encountered with surfaces designed for specific biological 
recognition such as the antigen-antibody interactions is the non-specific 
adsorption of other proteins (Veronese 2001). In this regard, the protein- 
resistant properties of a PEG surface are advantageous. Ligands including 
proteins, peptides and sugars can be attached to the distal end of these PEG 
chains creating substrates that recognize a specific molecule with minimised 
nonspecific adsorption of other components (Veronese 2001). This approach 
has been shown to be useful in regionally selective microarchitectured 
scaffolds fabricated from biodegradable polymers for spatial organization of 
co-cultured cells with different functions. A similar surface engineering was 
performed by Patel et al., who developed a method of generating micron-scale 
patterns of any biotinylated ligand on the surface of a biodegradable block 
copolymer of PLA and PEG (Patel et al. 1998). The polymer is biodegradable 
and resistant to non-specific protein adsorption, and the biotin moiety at the 
distal end of the PEG segment allows surfaces to be biospecific by binding 
avidin-conjugated ligands. The synthesis and characterisation of PLA-PEG- 
biotin, which forms the foundation of our self-assembling scaffold, is discussed 
in Chapter 3. 
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1.2.2 Design criteria for polymer scaffolds in tissue engineering. 
There are a number of biological, physical and chemical conditions required 
for the implementation of scaffolds for cell transplantation and tissue ingrowth. 
These are broadly split into five main categories: 
1. Biocompatibility and/or cell-interactive properties 
2. Porosity 
3. Biodegradability 
4. Mechanical properties 
S. The use of the scaffold in controlled release. 
1.2.2.1 Biocompatibility and cell-polymer interactions 
Cells recognize synthetic materials through a complex protein layer, which 
forms immediately on the material upon contact with body fluids 
(Drumheller. P 1998). This relation between material properties and cellular 
responses, mediated by the intervening protein layer, has complicated the 
development of biomaterials. Before the advent of biodegradable materials in 
the use of surgical procedures, polymer implants were intended to remain inert, 
thus unaffected by reactions with the surrounding tissues. As a result, cell- 
polymer interactions were first studied for the purpose of preventing or at least 
minimising the interactions (Agrawal 1998). Recent progress has been made by 
incorporating biologically active structures into the material, to permit direct 
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cellular interaction with the material (Drumheller and Hubbell 1995). These 
advances are based on the molecular biology of cell adhesion; specifically, the 
identification of small domains in the adhesion proteins of the extracellular 
matrix that bind to adhesion receptors on the surface of cells has been critical 
(Figure 1.5)(Drumheller. P 1998). Oligopeptide copies of these adhesion- 
promoting peptides can be synthesized and incorporated into materials, either 
in the bulk or as surface modifications. These approaches toward 
biofunctionalization provide a method to control biological interactions directly 
through material design. 
Hubbell and co-workers have characterized the conditions under which the 
minimal cell binding oligopeptide sequences such as arginyl-glycyl-aspartate 
(RGD), which are found in many cell adhesion proteins, is capable of 
supporting adhesion in cells such as the fibroblast (Massia and Hubbell 1990). 
It was observed that a surface density of 10 fmol/cm2 of surface coupled RGD 
ligand was enough to promote normal cell spreading, clustering of the cell- 
surface receptors, and organization of a normal cytoskeleton, corresponding to 
about 140nm distance between peptide ligands (Massia and Hubbell 1991). 
Numerous schemes have been developed for the incorporation of such 
adhesion ligands into both biostable and biodegradable polymer surfaces. 
These methods are generally based on adsorption, physical immobilisation or 
covalent binding. Quirk et al have developed a physical entrapment method 
whereby PLA is exposed to a partial solvent system containing poly L-lysine 
(PLL). 
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Figure 1.5 Integrin/proteoglycan (PG) interactions in cell-extracellular 
matrix (ECM) adhesion adapted from (Drumheller and Hubbell 1995) 
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This causes the formation of a gel layer in the PLA in which PLL diffuses into. 
Addition of a non-solvent excess results in immobilisation of the PLL. The 
attachment of RGD to PLL prior to this surface modification has been 
demonstrated to greatly enhance cell interactions (Quirk et al. 2001). Langer 
and co-workers at the Massachusetts Institute of Technology (MIT) have 
developed copolymers of the poly (lactic acid) with lysine providing sites for 
facile grafting of such peptide-based adhesion ligands (Barrera et al. 1993; 
Hrkach et at 1995; Cook et at 1997). A further method for presenting peptide 
sequences is the PLA-PEG-biotin copolymer developed by Shakesheff and co- 
workers. The universal coupling system via a biotin: avidin: biotin sequenced 
approach avoids possible disadvantages of covalent chemical attachments such 
as harsh reaction conditions and inefficient coupling or purification methods 
and allows for the facile surface presentation of peptides such as RGD 
(Cannizzaro et al. 1998). Clearly, the modification and functionalisation of 
polymer surfaces is a very active area of research. Microlithography 
techniques, which allow fine control of the surface texture is another 
illustration of surface modification in view of controlling, cell adhesion (Curtis 
and Clark 1990). Such techniques are reviewed further in Chapter 4 where 
lithography was employed to assess cell interactions with defined pore 
features, which are an important aspect of three-dimensional porous scaffolds. 
1.2.2.2 Pore size and morphology 
Three-dimensional porous polymer matrices possess several advantages for 
tissue reconstruction, including an increased area for cell anchorage and an 
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increased volume for cell growth, migration and effective fluid-phase transport 
of nutrients (Vacanti et al. 1994). The morphology of scaffold pores can 
critically determine the performance of an implanted scaffold, including the 
rate of tissue ingrowth. A high surface area favours cell attachment and growth, 
whereas a large pore volume is required to accommodate and subsequently 
deliver a cell mass sufficient for tissue repair (Freed et al. 1994). This has been 
demonstrated by transplantation of hepatocytes for the engineering of new liver 
tissue. (Cima et al. 1991; Kaufmann et al. 1997). When scaffolds are implanted 
in vivo, porous polymeric implants are often invaded by vascularized fibrous 
tissue. Predicting such behaviour is important because ingrowth in this manner 
can improve the survival of cells such as the hepatocytes, but has also shown to 
dramatically decrease the porosity of the implant (Mikos et al. 1993) (Mooney 
et al. 1997). Table 1.2 shows that pore size, not chemical composition, has the 
predominant influence on the vascularization of an implant. Implants show 
optimal vascular induction, where pores are large enough for cell and tissue 
infiltration but not large enough to allow fibrous deposit (Sharkawy et al. 
1998). Larger pores have also been shown to round macrophages, resulting in 
favourable angiogenic factor secretion, whilst smaller pore sizes, lead to 
macrophage spreading, which promotes fibroblast proliferation (Padera and 
Colton 1996). 
Highly porous biomaterials are also desirable for the easy diffusion of waste 
products from the implant (Mikos et al. 1993; Kim and Mooney 1998), which 
is a major requirement for regeneration of highly metabolic organs such as the 
liver and pancreas. 
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Table 1.3 shows the influence of porosity on diffusion and permeability properties. 
The surface area/volume ratio of a porous material depends on the density and 
average diameter of the pores. The optimum porosity varies with tissue types such as 
cartilage with minimal porosity constraints, to liver which requires pores with a 
minimum diameter of 60µm (Athanasiou et al. 1998) (Cima et al. 1991; Kaufmann et 
al. 1997). A scaffold suitable for organ and tissue regeneration must also contribute 
towards the organisation and direction of cell growth and ECM production. It has 
been shown that porous matrices with well-defined networks of interconnected pores 
take a significant role in this organization (Freed et al. 1994; Lu et al. 2000). The 
degree of porosity also has a significant impact on the rate of degradation with higher 
porosities reducing pH levels by easy removal of acidic oligomers thereby preventing 
autocatalytic degradation (Lu et al. 2000). 
1.2.2.3 Biodegradability 
When the ECM production is large enough to provide cells with a natural 
environment, the polymer scaffold degrades away at a controlled rate. Ideally, it 
should be completely resorbed, and natural physiological and metabolic pathways 
should eliminate the biodegradation products in order to avoid risks of unfavourable 
tissue reactions. 
The ideal lifetime of a biodegradable polymer scaffold depends on the application and 
particularly on the time required for the tissue or organ regeneration. 
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Pore size (µm) Material Vascular density Permeability (x10" 
(no. Per mm2) cm/s) 
700 PVA 55 0.71 
60 PVA 116.3 3.89 
5 PVA 73.7 1.37 
5 PTFE 67.5 0.65 
0.5 PTFE 35.2 1.47 
0 PVA 30.5 1.62 
Tablel. 3 Effect of porosity in biomaterial implants on transport properties 
(Sharkawy et al. 1997; Sharkawy et al. 1998; Sharkawy et al. 1998). 
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Thus, the success of a biomaterial in tissue engineering depends largely on how its 
biodegradation rate can be controlled. Certain scaffolds are thought to exhibit 
accelerated degradation at times owing to autocatalysis, which may be as a function of 
porosity. Poly a-hydroxy acids break down through a hydrolytic degradation pathway 
that leads to lactic acid/glycolic acid, which enter the tricarboxylic acid cycle and are 
eventually excreted. Thus, as these materials undergo hydrolytic breakdown, they 
release acidic by-products. An acidic environment can accelerate hydrolysis of these 
polymers (Lunt 1998; Holy et al. 1999). If the implants are structurally able to allow 
sufficient fluid flow through the interior, the by-products can be evacuated quickly. If 
however, diffusion is restricted by a non-porous environment, acidic by-products can 
accumulate within the implant resulting in adverse reactions from the surrounding 
tissue (Agrawal et al. 2000) (Mooney et al. 1995). One of the major advantages of 
degradation is that the scaffold can act as a controlled release device delivering 
growth factors over a sustained period of time (Sheridan et al. 2000). 
1.2.2.4 Scaffolds as controlled release devices 
A last criterion, which can influence the choice of polymer as biomaterial, is the 
possibility of incorporating bioactive molecules, such as drugs or growth and 
differentiation factors (Lee et al. 2000). Indeed, the controlled release of tissue- 
specific growth factors from the polymer scaffold may in some cases, considerably 
enhance the process of organ and tissue regeneration. Examples of growth factors 
include nerve growth factor (NGF) for nervous tissue regeneration (Bellamkonda and 
Aebischer 1994; Smith and Browne 1998), basic fibroblast growth factor (bFGF) for 
wound healing (Bonassar and Vacanti 1998), bone morphogenetic proteins (BMPs) 
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for cartilage (Saltzman et al. 1999) (Fujisato et al. 1996) and bone remodelling 
(Hollinger and Leong 1996), and angiogenic growth factors for the control of 
vascularization (Sondell et al. 1999). In tissue-engineered devices, there are two 
different potentially different delivery systems. Growth factors can be incorporated 
directly into the scaffold during or after fabrication (Babensee et al. 2000). In a 
biodegradable system, the growth factor would be released as the scaffold degrades to 
induce tissue regeneration. Growth factor, directly incorporated into a biodegradable 
polymer scaffold, is released by a diffusion-controlled mechanism that is regulated by 
the median pore size (Whang et al. 1998). The protein can also be released by an 
erosion mechanism or a combination with diffusion. Alternatively, the growth factor 
delivery device, in the form of microparticles, nanoparticles, fibres or injectable 
complexes, can be incorporated into the scaffold (Mooney et al. 1996). This method 
of delivery is also desirable because growth factors have short biological half-lives. 
For an example, platelet derived growth factor (PDGF) has a half-life of less than two 
minutes when injected intravenously (Babensee et al. 2000). 
Specific growth factors, released from the delivery device would aid in the induction 
of cell migration, proliferation and differentiation or improve engraftment of seeded 
cells, supported by the polymer scaffold, for more efficient tissue regeneration 
(Babensee et al. 2000). There should be no interference of the growth factor delivery 
device and the tissue engineered device. The two components should function 
synergistically. Growth factors released from a device may interact with matrix 
proteins in the scaffold or in the surrounding tissue to enhance their local 
bioavailability or provide increased stability (Babensee et al. 1998; Lee et al. 2000). 
A novel approach to the use of growth factors is to immobilise them onto the surface 
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of scaffolds, which in conjunction with adhesive peptides, could mimic membrane- 
anchored growth factors such as heparin-binding epidermal growth factor (Ito 1998). 
In summary, cell scaffolds for tissue engineering should meet several design criteria: 
1. The surface should permit cell adhesion and growth (Hench 1998). 
2. Neither the polymer nor its degradation products should provoke inflammation 
or toxicity when implanted in vivo (Peter et al. 1998). 
3. The material should be reproducibly processable into three-dimensional 
structures. 
4. There should be controlled porosity in order to provide a high surface area for 
cell-polymer interactions, sufficient space for extracellular matrix 
regeneration, and minimal diffusional constraints during in vitro culture (Tjia 
and Moghe 1998). 
5. The scaffold should resorb once it has served its purpose of providing a 
template for the regenerating tissue, since foreign materials carry a permanent 
risk of inflammation (Ronneberger et al. 1997). 
6. The scaffold degradation rate should be adjustable to match the rate of tissue 
regeneration by the cell type of interest (Ratner et al. 1990; Freed et al. 1994). 
Such scaffolds should allow attachment of isolated cells to a polymeric support 
structure that has suitable surface properties for guiding the reorganisation and growth 
of cells. These should be designed so that the cells could survive by diffusion once the 
cell-polymer construct was implanted. Ideally, the cell-polymer construct would 
become vascularized in conjunction with expansion of the cell mass following 
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implantation, and both these processes could be influenced if desired by release of 
appropriate growth factors at the site (Fausto et al. 1995). The ability of scaffolds to 
conform to all these conditions is also highly dependent on the manufacturing 
process. 
1.2.3 Manufacturing methods 
The conventional processing techniques and porogen methods used in the polymer 
industry are unsuitable for producing medical implants. Indeed, additives are 
commonly used, such as surfactants, plasticizers, stabilizers and lubricants, which can 
be toxic to cells. The properties of the polymer, the components involved and the 
shape of the scaffold required dictate the choice of processing technique for the 
manufacture of polymer scaffolds (Thomson et al. 1995). 
The traditional methods for scaffold fabrication include fiber bonding, solvent casting, 
membrane lamination and melt molding (Thomson et al. 1995; Lu and Mikos 1996). 
Mooney et al demonstrated that an effective method of stabilizing PGA scaffolds was 
to spray solutions of PLLA/PLGA in chloroform (1-15% w/v) over a PGA mesh 
using a nitrogen stream to atomize the polymer solution. Since PGA is very weakly 
soluble in chloroform, the PGA fibres are effectively unchanged by the process 
(Mooney et al. 1996). Porosity in scaffolds is commonly formed by particulate 
leaching. This is achieved by evaporating chloroform from solutions of PLLA 
containing sodium chloride particles. These polymer films with entrapped salt 
particles are then leached in water to remove the particles resulting in highly porous 
films (Kaufmann et al. 1997). These same films can then also be formed into hollow 
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tubes (Mooney et al. 1995). A similar system has been used by Shoichet and co- 
workers where glucose crystals were dispersed within a PLGA solution in dimethyl 
sulfoxide (DMSO) (Holy et al. 1999). These methods appear to be however, most 
effective for only thin films or structures with thin walls. 
Novel methods of manufacturing scaffolds include a prototyping technology that has 
been developed at MIT where a binder is expelled through a print head nozzle onto a 
powder bed. The scaffold is built by layers of powder and binder in a method that can 
create complex three-dimensional shapes. The highly toxic solvents however prevent 
incorporation of biological agents such as cells or growth factors during fabrication 
(Hutmacher 2000). Wintermantel et al have developed a novel method for scaffold 
formation using minimally invasive approaches. They introduced a thread like 
material and delivered it through an injection canal (e. g. cannula). A fluid stream 
acted as a carrier for the "lycra monfilTM" based material, which was unreeled from a 
spool creating a porous scaffold in the form of a tangle (Wintermantel et al. 1996). 
Langer and co-workers have produced macroporous polymer foams by a hydrocarbon 
templating method in which a viscous polymer solution of PLA in chloroform and a 
particulate hydrocarbon porogen such as paraffin was compacted in a Teflon mold. 
The polymer/ solvent/ porogen phase was then extracted in a hydrocarbon solvent, 
such as hexane which is a non-solvent for the polymer but miscible with the polymer 
solvent. This resulted in the porogen becoming extracted and rapid precipitation of a 
porous polymer phase (Shastri et al. 2000). 
Defined three-dimensional biodegradable foams have also been shaped by lamination 
of highly porous PLLA and PLGA membranes previously prepared by solvent casting 
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and salt leaching. The membranes with the appropriate shape are solvent impregnated, 
then stacked up in a three-dimensional assembly with continuous pore structure. 
Computer-assisted modelling can then help to design templates with the desired 
implant shape. The in vivo prevascularization of these laminated foams has been 
demonstrated by the injection of a sufficient mass of e. g. hepatocytes for liver 
regeneration (Mikos et al. 1993). Finally Mooney et al have demonstrated that the use 
of supercritical carbon dioxide (C02) is a promising approach in creating polymer 
scaffolds (Mooney et al. 1996). This was achieved by exposing poly a-hydroxy acids 
to CO2 gas (5.5 MPa, 72 hr). The CO2 gas pressure was decreased resulting in 
thermodynamic instability and the dissolved CO2 nucleated and formed pores within 
the polymer matrix. As the method avoids the use of organic solvents, it is possible to 
then incorporate growth factors into the scaffold without loss of biological activity 
(Howdle et al. 2001). 
1.3 In situ solidifying biomaterials 
There are a number of applications in tissue engineering and drug delivery that 
require the development of novel biomaterials that can be transformed from liquid 
precursors to solids in the final form. Applications for the use of in situ transforming 
materials include cell delivery; barriers for tissue regeneration guidance; injectable 
temporary scaffolds for tissue regeneration; tissue adhesives for healing and injectable 
controlled release devices for local drug delivery (Hubbell 1996; Hubbell 1996; 
Hubbell 1998). 
However, the most significant advantages of in situ transformation from liquid 
precursors to solids are, that large objects can be delivered via minimally invasive 
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surgical devices, and that implants can be made that conform to complex tissue 
shapes. 
The ideal injectable polymer would need to satisfy the following design criteria: 
1. It would polymerise in situ in a timely fashion without detrimental effects to 
the surrounding tissue such as a temperature rise. 
2. It should fill defects of various shapes and sizes and have the correct 
mechanical and physical properties for a particular application. 
3. It would maintain these mechanical properties as it degrades. 
4. It must degrade into biocompatible degradation products according to a 
predetermined degradation profile, have a long shelf life, be sterilizable 
without loss of its properties, and be available to the surgeon in the sterile 
operating field on short notice (Hubbell 1996; Hubbell 1998; Peter et al. 
1998). 
In recent years, materials have been developed that can operate near body 
temperature, use non-toxic solvents, are based on macromolecular and hydrophilic 
precursors and do not liberate cytotoxic leaving groups as the transformation 
proceeds. These include materials that are converted from biologically acceptable 
liquid precursors into solids by photochemically initiated free radical reactions. For 
example, Hubbell and co-workers have copolymerised oligomers such as lactic or 
glycolic acid at the hydroxyl end groups of polyethylene glycol (PEG) blocks. 
Acrylating the resulting terminal hydroxyls resulted in the formation of a telechelic 
diacrylate of the ABA block copolymer of polyethylene glycol (B) and poly (lactic 
36 
Chapter 1: Introduction 
acid) (A) (Han and Hubbell 1996). The water-soluble diacrylate yields a crosslinked 
hydrogel when polymerised. These materials have potential as mechanical barriers in 
controlled healing. This was demonstrated when the photopolymerisation process was 
used to block the deposition of blood clots on the arterial surface of an injury in 
animal studies, resulting in favourable wound healing (Hubbell 1996). Similarly, a 
method has been developed at MIT which can encapsulate chondrocytes through a 
photopolymerising system consisting of poly (ethylene oxide)-dimethacrylate and a 
polyethylene glycol semi-interpenetrating network (Elisseeff et al. 1997). 
Photoinitiated polymerisation is also possible with more hydrophobic macromolecular 
precursors that yield on transformation, rigid materials that are capable of bearing 
mechanical loads. For example, unsaturated macromers based on polyesters formed 
from fumaric acid, polyethylene glycol and polypropylene fumarate which can be 
polymerised in situ to form materials that may also be useful in the repair of bone 
(Peter et al. 1997; He et al. 2000). 
In addition to transformations based on free radical polymerisation, other groups have 
recently contributed new technologies for in situ transformation, based on alternative 
mechanisms of solidification. Such transformations may occur because of a change in 
pH or temperature, ionic crosslinking, solvent exchange or crystallisation. Block 
copolymers of polyethylene glycol and propylene glycol, for example, display a lower 
critical solution temperature and can form liquids at cold temperatures and gels at 
body temperatures. Kim and co-workers have developed block copolymers of poly 
(lactic acid) with polyethylene glycol, and these copolymers display an upper critical 
solution temperature, forming liquids at temperatures around 45°C and gels at body 
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temperature (Jeong et al. 1997). Another thermally triggered system that combines 
ionic crosslinking has been proposed by Westhaus and Messersmith. In their system, 
liposomes with entrapped calcium chloride were suspended in an aqueous alginate 
solution. When heated to 37°C, the liposomes released calcium ions into the alginate 
solution crosslinking it into a gel (Westhaus and Messersmith 2001). These injectable 
materials clearly have great potential in the development of non-invasive therapies in 
tissue-engineering and drug delivery. 
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1.4 Aims of project: 
This introductory chapter has established the concept of tissue engineering. Materials 
used as scaffolds for tissue growth are required to have defined properties; favourable 
cell-polymer interactions, porosity, degradability, mechanical strength and controlled 
release properties. Recent advances in the field have also demonstrated novel 
materials that can transform in situ thereby providing a minimally invasive technique 
for delivery of polymer/polymer-cell constructs. A major obstacle with these in situ 
transforming materials, in comparison to traditional water-insoluble scaffolds is that 
such hydrogels lack large interconnected porous networks and, hence, the barrier of 
diffusion to signalling and nutrient molecules limits tissue formation. In addition, the 
mechanism of gelation may damage cells, hence, prohibiting co-administration of the 
cells. 
The work presented in this thesis shows the development of an injectable material that 
is not only minimally invasive but also fulfils the requirements of scaffolds used in 
tissue engineering applications. The polymer designed for this application is 
degradable and capable of facile engineering to present a cell-adhesive surface. The 
scaffold is porous with tailorable mechanical properties and is also capable of 
controlled release (e. g. growth factors). The novel crosslinking process provides a 
highly effective method of seeding the scaffold with viable cells that are distributed 
throughout. Chapter 3 describes the synthesis and characterisation of the polymer that 
forms the foundation of the scaffold. The pore-cell interaction is then probed in 
Chapter 4 to gain a deeper understanding of the relationship between them. Finally in 
Chapter 5 and 6, the development of the injectable porous scaffold is described: from 
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the physico-chemical properties through to the self-assembly of three-dimensional 
scaffolds and the entrapment and delivery of viable cells. 
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CHAPTER 2 
THEORY OF INSTRUMENTAL METHODS 
The studies presented in this thesis have utilized a range of analytical 
techniques. These range from methods used to characterise the bulk and 
surface properties of the polymer to methods that characterise the formation of 
our polymer scaffold, both quantitatively and qualitatively. This chapter 
provides a brief theoretical background to some of the analytical techniques 
used. Specific experimental details are then additionally described within the 
materials and methods section of each of the results chapters. 
41 
Chapter 2: Theory of instrumentation 
2.1 Polymer characterisation: 
2.1.1 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry (DSC) is a technique for studying thermal 
transitions in materials such as polymers (Mi and Zheng 1998). The DSC 
equipment has an adiabatic chamber which houses two pans, one to hold the 
polymer sample and the other acts as a reference pan, which is left empty. Each 
pan is located above a heater that applies heat to each of the pans at a specific 
controlled heating rate. Both heaters are electronically controlled so as to 
achieve the same temperature in both pans. The pan containing the sample thus 
has a larger heat output. The difference in the heat output of the sample heater 
and the reference heater at a given temperature provides the heat flow, which 
when divided by the heating rate results in the heat capacity of the sample. 
DSC can thus yield valuable thermal information on materials like 
biodegradable polymer. A plot of the heat flow against temperature will show 
shifts, for an example, at the glass transition temperature, Tg, above which 
polymers have a higher heat capacity. Outputted data is recorded and analysed 
by established software that extracts the measured data. DSC analysis requires 
a sample of only a few tens of milligrams in mass, and between five and six 
millimetres in diameter. 
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2.2 Quantitative measurement of scaffold formation 
2.2.1 Surface Plasmon Resonance (SPR) 
SPR is a technique that enables the real-time monitoring of dynamic processes, 
such as the interaction of biomolecules with a surface, without the need for 
labelling molecules. SPR can provide information regarding both the extent of 
biomolecular attachment to a surface and the kinetics involved with such 
processes. In this thesis, SPR has been employed in studies detailed in Chapters 
3 and 5; to investigate the biotin-avidin mediated interaction of our self- 
assembling scaffold. 
When light travels through a transparent medium, for example glass, the 
proportion of light which is reflected off the glass interface increases as the 
angle of incidence increases until a critical angle, A,, is reached after which all 
the light is reflected back (total internal reflection). 
In SPR, a glass slide is coated on one side with a thin film of noble metal 
(typically silver or gold). At a specific angle greater than A,, the light is no 
longer totally internally reflected. At this angle, termed the SPR angle (O 
, p, ) the 
incoming light is able to couple with free oscillating electrons (plasmons) in 
the metal film. Coupling occurs when the wave vector of the non-propagating 
evanescent wave emanating from the surface equals the oscillating frequency 
of the surface electrons causing them to resonate i. e. a surface plasmon is 
resonantly excited. The transfer of energy from the incident light to the metal 
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film causes a reduction in the intensity of the reflected light, which can be 
detected. 
Surface plasmons can only occur at the interface between two materials with 
different dielectric constants, for example a metal-water interface. The wave 
vector of a surface plasmon is influenced by the refractive index of the 
dielectric medium above the metal surface. The distance over which this 
technique is sensitive to refractive index changes is of the order of the 
wavelength of light employed. If the index immediately above the metal 
surface changes, for example because of biomolecules attaching to it, then a 
change in the angle of incidence is needed to generate resonance. Therefore, 
SPR can be utilized to profile the attachment of biomolecules from a bulk 
solution to a surface by monitoring the O, pr with respect to time. 
2.2.1.1 SPR Instrumentation 
The SPR system (Ortho Clinical Diagnostics, Chalfont St. Giles, U. K) 
employed for traces obtained in Chapters 3 and 5 is shown schematically in 
Figure 2.1. A laser light source operating at a wavelength of 780 run was 
focussed through a glass prism and onto the underside of a thin silver film 
(approximately 50 nm thick) supported on a glass slide (Ortho Clinical 
Diagnostics, Chalfont St. Giles, U. K). The glass slide was optically coupled to 
the prism using immersion oil (Stephens Scientific, Riverdale, New Jersey, 
U. S. A. ). In Chapters 3 and 5, the silver films were modified, to present biotin 
surfaces. 
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Figure 2.1 Schematic of SPR adapted from (Green et a!. 1997; Green et al. 
1999) 
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The reflected light was focussed onto an array of charge-coupled detectors and 
their data output processed within the SPR software. The flow of liquid across 
the silver surface was confined to three isolated flow channels within a 
thermoregulated copper block (equilibrated at 34°C). Sample solutions of 1 ml 
were introduced through a loop valve system to the flow channels at a rate of 4 
µL s"1 by means of a syringe pump. The syringe pump allowed the 
incorporation of two different syringes enabling two SPR channels to be 
monitored simultaneously. All sample buffers were degassed prior to use with 
helium gas to avoid the introduction of air bubbles into the SPR channels. 
During protein binding studies, the change in SPR angle was monitored in 
units of millidegree angles (mDA) where 1 mDA = 0.001°. The obtained traces 
were displayed as plots of SPR angle (mDA) versus time (s). 
2.2.2 Photon Correlation Spectroscopy (PCS) 
Photon correlation spectroscopy (PCS) or dynamic light scattering is a valuable 
technique for particle size analysis of submicrometre particulates. The 
technique consists of focussing a monochromatic laser beam at a particulate 
dispersion and analysing the statistical intensity fluctuations of the scattered 
light. These fluctuations are due to the random Brownian motion of the 
particles, the rate of which is inversely proportional to the particle size at 
constant temperature. 
Experimentally, a photo multiplier is used to detect the scattered light at 90°C 
to the incident beam and the average scattered intensity is correlated as a 
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function of the correlation time rc. the derived intensity decay or 
autocorrelation function G(ti,, ) is directly related to the diffusion coefficient of 
the particles, CD: 
G(ti, ) =1+ exp(-2CDQ2tc) 
Q is the scattering vector given by: 
Q= (4t/X)sin(0/2) 
Where k is the wavelength of the incident light and 0 is the scattering angle. 
The hydrodynamic diameter, Dhyd, is then obtained directly from the diffusion 
coefficient by means of the Stokes-Einstein equation: 
CD = kT/3 t11Dhyd 
Where k is the Boltzmann constant, T is the absolute temperature and rl the 
solvent viscosity. 
For polydisperse systems, the autocorrelation function consists of a sum of 
exponentials. The simplest treatment of such systems to provide the average 
particle size and the polydispersity index of the distribution is cumulant 
analysis. This method assumes that the distribution of exponentials is 
unimodal, and so the mean size is described by the "best fit average" 
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exponential. The log of the normalised correlation function is fitted to a 
polynomial of the following form: 
Loge(G(ic)) = Ko 
- 
K1T,, + y2 KZtc2......... 
Where Ka, K1, K2....... are the coefficients of the cumulants fit determined by 
a simple least squares fitting procedure. Kl describes the average diffusion 
coefficient, CD: 
Kl = 2QZCD 
This yields the average hydrodynamic particle diameter, Dhyd 
2.2.2.1 PCS instrumentation 
The PCS equipment used was a Malvern 4700 series instrument (Malvern 
Instruments, Malvern, U. K. ) with vertically polarised light supplied by an 
argon-ion laser (Cyonics, San Jose, U. S. A. ) operated at 20 mW. The 
nanoparticle dispersions were diluted using filtered, deionised water to achieve 
a suitable scattering intensity. Six 30 second measurements of each sample 
were made at a temperature of 25.0 ± 0.1°C and at a measuring angle of 90°C 
to the incident beam. The correlation decay functions were analysed by the 
cumulants method to determine the average particle diameter and 
polydispersity index. The values presented are the mean of two replicate 
samples together with the standard deviation. 
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2.2.3 Coulter LS230 
Aggregate structure has been known to be of great importance in solid-liquid 
separation processes such as sedimentation and influences the strength of the 
aggregates. Particle characterization by light-scattering techniques has the 
advantage of allowing estimation of a wide range of particle size in a rapid and 
non-destructive manner. (Selomulya et al. 2001) 
The evolution of size of the aggregates was monitored using a particle size 
analyser (Coulter LS230). The instrument applies the principle of forward light 
scattering by particles to measure the particle size distributions. The size 
distributions were estimated by fitting the intensity of the scattered light (?, = 
750 nm) as a function of the scattering angle (0 = 0.017-34°C). They were then 
compared by the instrument to the scattering patterns of spherical particles of 
the same size calculated by the Mie model of light scattering by particles with 
significant differences only if particles are very non-spherical. 
2.2.4 Sedimentation 
Sedimentation ranks as one of the oldest methods of particle size measurement 
and is capable of providing accurate results with good size resolution. 
Although a very large number of measurement methods have been based on 
sedimentation, most vary only in the method used to study the gradual 
separation of the particles, and the fundamental physics of the system 
- 
the 
settling of particles in a gravitational field is identical to all. 
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A remote system of estimating the amount of material in suspension at a 
particular point would be an effective method of monitoring sedimentation. An 
ideal technique would be to use a light beam passing through the suspension, 
and estimate the particle concentration from the attenuation of the light beam. 
This can be achieved by UV-Vis spectroscopy, which measures the attenuation 
of a beam of light after it passes through a sample. Absorption measurements 
can be at a single wavelength or over a range of spectrum. The particle 
concentration can be obtained from the absorption by assuming that the 
particles cause a loss of light from the beam which is proportional to their 
cross-sectional area. Particles of diameter d will obscure an area, which is 
proportional to the square of their diameter; the obscured area ad is written as: 
ad _kddz 
where ka is a constant dependent on the shape of the particles (e. g. it is n/4 for 
spherical particles). 
2.2.5 Rheological determination of mechanical properties 
2.2.5.1 Principles of dynamic (oscillatory) rheological measurements 
In oscillatory rheological measurements, a small amplitude sinusoidal strain 
with frequency co (rad s) is applied to the system, and the sinusoidal stress 
that is generated is measured simultaneously. 
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This is illustrated schematically for a viscoelastic system in Figure 2.2, which 
shows the stress response to a sinusoidal strain of amplitude yo. The amplitude 
of the stress is to and it oscillates with the same frequency, but out of phase. 
The phase angle shift between the two is given by: 
0p= At. cw 
where At is the time shift between the two waves. If a sinusoidal strain wave 
were applied to a perfectly elastic solid (Hookean solid), the resultant stress 
wave would be completely in phase with the strain (0=0°). In contrast, for a 
purely viscous liquid (Newtonian liquid) the stress would be exactly 90° out of 
phase with the strain (maximum stress corresponding to maximum strain rate). 
The behaviour of a viscoelastic material lies somewhere in between these two 
extremes and the phase shift (00 <0< 90°) depends on the relative amounts of 
elastic and viscous behaviour at the frequency of oscillation. 
In oscillatory shear, the complex shear modulus G*, describes the relationship 
between the stress and strain. G` is vectorially resolved into two components; 
the elastic or storage modulus, G' (the real part of the complex modulus) and 
the viscous or loss modulus, G" (the imaginary part of the complex modulus): 
G*=G'+iG" 
From the stress and strain amplitudes (to and yo respectively) and the phase 
angle shift, 0, it is possible to determine all three moduli as follows: 
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Figure 2.2 The relationship between harmonic shear strain (y) and 
harmonic shear stress (ti) for a viscoelastic material adapted from Bohlin 
software. 
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IG'1= do/Yo 
G' 
_ 
IG*I cos 0 
G" = IG*I sin O 
G' is a measure of the energy stored elastically by the system, whereas G" is a 
measure of the energy dissipated as viscous flow. 
2.2.5.2 Rheological measurements 
Dynamic (oscillatory) measurements were performed using a Bohlin rheometer 
interfaced with an IBM computer. This instrument operates in the frequency 
range 10"3-20 Hz and it has interchangeable torsion bars covering a wide range 
of sensitivities. In this work, measurements were made using a frequency range 
of 0.01 
-5 Hz at 37 ± 0.1°C. A cone and plate method using a 40mm diameter 
cone with a 4° cone was employed in these studies. A solvent trap was fitted to 
prevent sample skinning or drying. Each sample was allowed to rest for 10 
minutes before making the rheological measurements. Initially the frequency 
was kept constant at 1 Hz and the strain amplitude increased stepwise (strain 
sweep), whilst measuring the rheological parameters G% G' and G". This 
enables the linear viscoelastic region to be defined, where G% G' and G" are 
independent of the strain amplitude at the given frequency. Measurements were 
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then made in the linear viscoelastic region as a function of frequency, at a fixed 
strain amplitude (frequency sweep). 
The measuring system in the instrument used a series of form factors to 
calculate shear stress and shear strain. Shear stress was equal to Cl multiplied 
by the torque, whilst shear rate was equal to C2 multiplied by the angular 
velocity. In the cone and plate method employed, Cl was 1/(2/3 x r3) and C2 
was 1/0 where r was the radius of the cone and 0 was the cone angle in radians. 
The viscosity was then calculated by dividing shear stress by shear rate. 
2.3 Qualitative assessment of scaffold formation 
2.3.1 Confocal Microscopy 
Confocal microscopy is a technique used to gain high resolution views of thick 
specimens by rejection of out of focus scattering (Tjia and Moghe 
1998)(Figure 2.3). This is achieved by an arrangement of diaphragms, which, 
at optically conjugated points of the path of the rays, act as a point source and 
as a point detector respectively. Rays that are out of focus are suppressed by 
the detection pinhole. The depth of the focal plane is, besides the wavelength 
of light, determined in particular by the numerical aperture of the objective 
used and the diameter of the diaphragm. At a wider detection pinhole, the 
confocal effect can be reduced. To obtain a full image, the image point is 
moved across the specimen by mirror scanners. 
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Figure 2.3 Schematic of Confocal microscope adapted from Leica website. 
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The emitted/reflected light passing through the detector pinhole is transformed 
into electrical signals by a photomultiplier and displayed on a computer 
monitor screen. Major improvements offered by a confocal microscope over 
the performance of a conventional microscope are: 
1. Light rays from outside the focal plane will not be recorded. 
2. Defocussing does not create blurring, but gradually cuts out parts of the 
object as they move away from the focal plane. The practical 
consequence is that these parts become darker and eventually disappear. 
This feature is called optical sectioning. 
3. True three-dimensional data sets can be recorded. 
4. Scanning the object in x/y-direction as well as in z-direction (along the 
optical axis) allows viewing the object from all sides. 
5. Due to the small dimension of the illuminating light in the focal plane, 
stray light is minimized. 
By image processing, many slices can be superimposed, giving an extended 
focus image which can only be achieved in conventional microscopy by 
reduction of the aperture and thus sacrificing resolution. 
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CHAPTER 3 
SYNTHESIS AND CHARACTERISATION OF A 
DEGRADABLE POLY (LACTIC ACID) 
- 
POLY 
(ETHYLENE GLYCOL) COPOLYMER WITH 
BIOTINYLATED END GROUPS. 
3.1 Introduction 
The criteria for the use of synthetic polymeric biomaterials as scaffolds in 
tissue engineering have been established in Chapter 1. The ability to develop 
materials that are capable of being processed into porous degradable scaffolds 
that mimic cellular recognition is a desirable strategy in tissue engineering. 
Similarly, materials that are capable of in situ transformations have great 
potential in facilitating minimally invasive therapies. In Chapter 3, we 
describe the synthesis of a polymer that can be processed into a scaffold that 
can comply with the requirements of both traditional water-insoluble porous 
scaffolds and injectable biomaterials. This material thus forms the foundation 
of our injectable self-assembling scaffold. 
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3.1.1 The biotin-avidin interaction in biomedical applications 
The binding of biotin and avidin is an established interaction in biomedical 
applications. Although many other ligand-binder interactions are described in 
the literature, the biotin-avidin or, biotin-streptavidin interaction has some 
unique characteristics that make it ideal as a general bridge system in a diverse 
range of uses (Gonzalez et al. 1997). For an example, changes in pH and 
repeated washings do not break the non-covalent interaction of the biotin and 
avidin bridge because its binding constant is 10'15 M '1, which is one of the 
strongest known biological interactions. The binding process is specific, 
ensuring it is the target molecule that is bound. Because biotin is a small 
molecule of 244.31 Daltons in size, conjugation of biotin with macromolecules 
can be achieved without significantly affecting their targeting ability 
(Diamandis and Christopoulos 1991; Lindqvist and Schneider 1996; Gonzalez 
et al. 1997). 
Table 3.1 lists the potential biomedical applications that use the biotin-avidin 
interaction. These include drug targeting, immunological assays, nucleic acid 
hybridisation assays, flow cytometry, electron microscopy, affinity 
chromatography, surface modification and attachment of biotin to membranes 
of cells. Avidin is also often used as a model for predicting protein interaction 
behaviour (Kaasgaard et al. 2001). 
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Applications Biotinylated moieties Avidin conjugate 
Immunological assays, flow Enzymes (ALP, ß- 
cytometry, cell sorting, galactosidase, glucose 
immunohistochemistry, western blots, oxidase, HRP), anti- 
nucleic acid hybridisation immunoglobulins 
Glyconjugate studies, mitogenic Lectins 
stimulations studies 
Enzymes (ALP, ß-galactosidase, glucose 
oxidase, HRP) flourophores (flourescien, 
cour grins, rhodamines, phycoerythrin, 
Texas Red), Eu3+-chelates, polystyrene, 
chemiluniinescent labels 
Localization of lectin receptors Anti-Lectins 
Electron Microscopy Ferritin, hemocyanin Ferritin, gold 
Affinity Chromatography Agarose, cellulose, Agarose 
hormones, liposomes, 
latex particles 
Amplification assays, receptor-ligand Anti-avidin, anti- 
interaction studies streptavidin 
Nucelic acid hybridisation, molecular Nucleotides, DNA Magnetic particles 
mass marker, DNA sequencing 
Hybridoma production Cells 
Table 3.1 Applications of the biotin-avidin interactions: (Green 1965; 
Leary et al. 1983; Diamandis and Christopoulos 1991; Chern et al. 1996; 
Lindqvist and Schneider 1996; Lynch et al. 1996; Gonzalez et al. 1997; Kaiser 
et al. 1997; Mahal et al. 1997) 
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Immobilized avidin/streptavidin can be used to purify and characterize various 
moieties of interest. For example, magnetic particles conjugated with avidin 
have been used to retrieve biotinylated DNA. Solid substrates used in this 
manner also purify DNA binding substances or separate cells tagged with 
biotinylated antibodies. Biotin modified submicron latex particles have been 
used to separate mixtures of avidin and lysozyme effectively (Chem et al. 
1996). The avidin was subsequently recovered from the particles by using 8M 
pH 1.5 guanidine-HCL solutions or autoclaving. Lynch et al have carried out 
comprehensive studies on the aggregation kinetics of biotinylated liposomes 
for affinity purification (Lynch et al. 1996; Lynch et al. 1996). 
Drug delivery applications for the biotin-avidin interaction include HIV and 
cancer treatment. For example, the potential of combining the avidin-biotin 
system with nanoparticle technology has recently been demonstrated in carrier 
systems with biotinylated drug derivatives for antisense therapy for HIV 
infections (Coester et al. 2000). Furthermore, whilst effective 
radioimmunotherapy in cancer therapy is limited by slow antibody clearance 
from the circulation, which results in low tumour to blood ratios and restricts 
the dose of radiolabelled anti-tumour antibody that can be safely administered. 
Avidin and streptavidin clearing agents have been shown to effectively 
complex and clear radioactive biotinylated antibodies from the circulation via 
the reticuloendothelial system (Marshall and Pedley 1996). Whilst 
immunogenicity of avidin limits its use in such applications, PEG modification 
of avidin has been shown to reduce the immune response. 
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Conjugation of biotin to polymers, proteins and sugars can be carried out in a 
number of ways. Table 3.2 lists a selection of the available biotin labelling 
strategies for polymers, proteins and carbohydrates. Other methods of avidin 
binding include direct conjugation of the polymer to avidin. For an example, 
Stayton and co-workers have developed a series of polymer-streptavidin 
complexes. This was achieved by reacting an S-H group from cysteine on the 
streptavidin with derivatized vinyl sulfone groups on the copolymer. One 
example is a poly (N-isopropylacrylamide)-streptavidin conjugate that displays 
temperature dependent binding of biotin. The polymer binds biotin at room 
temperature and releases it at 37°C. They have also produced a pH-sensitive 
copolymer of NIPAAm and acrylic acid and conjugated this copolymer to 
streptavidin. Lowering the pH caused the polymer to collapse blocking biotin 
binding. Raising the pH caused the polymer to fully hydrate allowing biotin to 
bind. Furthermore, poly (2-propylacrylic acid)-streptavidin complexes have 
been shown to have pH dependent haemolytic properties capable of disrupting 
membranes of red blood cells (Stayton et al. 1995; Ding et al. 1999; Lackey et 
al. 1999). 
3.1.2 Poly (lactic acid)-polyethylene glycol-biotin (PLA-PEG-biotin) 
Poly (lactic acid)-polyethylene glycol-biotin (PLA-PEG-biotin) is a degradable 
polymer with protein resistant properties and a universal linkage system that 
allows both self-assembly of the polymer and that can undergo rapid surface 
engineering in aqueous media to create biomimetic surfaces (Figure 3.1) 
(Cannizzaro et al. 1998). 
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Moiety for Reactive group on Biotinylation Conditions Ref 
biotinylation moiety reagent 
Poly (ethylene Functionalised NH2 
glycol) group 
Proteins Amine 
Poly 
vinylpyrrolidone 
Glycoproteins 
Poly (pyrrole-biotin) 
Table 3.2 
sulfhydryl 
Tyrosyl, hystidyl 
Carboxyl groups 
NHS-biotin DMF/ET3N for 24hr at room (Kaiser et al. 
temp. 1997) 
N-hydroxy- Alkaline (pH 9.1) bicarbonate 
succinimide solution. 
ester of biotin 
(NHS-biotin) 
Iodoacetyl-LC- 
biotin 
P- 
diazobenzoylbio 
cytin 
Biotin hydrazide A water soluble carbodiimide 
reaction 
Radical inititated Derivatized 
polymerisation of N- azonitrile 
vinyl pyrrolidone initiator with 
biotin 
Solution polymerisation in 
dimethylformamide 
Sugar moities Biotin-LC- Oxidising vicinal hydroxyl 
hydrazide groups into aldehydes using 
NaI04. Reaction found to be 
inferior to biotin-NHS 
Pyrrole ammonium Pyrrole Electro-copolymerisation of 
derivative modified biotin Pyrrole ammonium derivative 
with pyrrole modified biotin 
by controlled potential 
electrolysis 
Biotin labelling strategies for polymers, proteins and 
carbohydrates 
(Diamandis and 
Christopoulos 
1991) 
(Ganachaud et al. 
1995) 
(Diamandis and 
Christopoulos 
1991) 
(Cosnier and 
Lepellec 1999) 
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Figure 3.1 Structure of PLA-PEG-biotin 
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Surface engineering and self-assembly of this polymer is dependent on 
biomolecular interactions between the biotin end group and the protein avidin. 
PLA-PEG copolymers and their use as an effective biomaterial in drug delivery 
and tissue engineering has been discussed in Chapter 1. PLA is the backbone of 
the polymer and provides structural integrity to any scaffold (Agrawal et al. 
1997; Hench et al. 1998; Lu et al. 1996; Han et al. 1996). Polyethylene glycol 
(PEG) has long been considered an attractive biomaterial because of its ability 
to resist protein adsorption (Holmberg et al. 1997; Deible et al. 1998; 
Holmberg et al. 1997 ; Park et al. 1998; Park et al. 1999). In PLA-PEG-biotin, 
PEG acts as a spacer group for the biotin thus improving biotin-binding 
capabilities by reducing steric hindrance. To utilise biotin in this manner, it is 
covalently linked to the PEG. Although traditionally covalently linked biotin 
derivatives showed greatly reduced affinities for avidin due to steric hindrance. 
High affinity and metastability of avidin-biotin interaction could be restored 
when 7-27 atom spacers were introduced between the biotin and the peptides. 
These spacers, however, were not effective against other steric hindrances 
created because the four-biotin binding sites on avidin are organised in two 
pairs on opposite sides of the receptor protein. Steric repulsion between 
adjacent biotinylated derivatives, thus allows the exploitation of only one site 
per pair in practice (Green 1965). The use of PEG spacers, however, optimises 
the biotin-avidin interaction when compared to that of avidin and d-biotin 
because the flexibility of the PEG chains further reduces the interaction of the 
individual components and decreases non-specific binding (Kaiser et al. 1997). 
Each biotin moiety on the PLA-PEG-biotin attaches to one of the four biotin 
binding sites on the tetrameric protein avidin leaving available binding pockets 
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for any biotinylated peptide sequences or ligands (Green et al. 1965; Lindqvist 
et al. 1996; Gonzalez et al, 1997; Weisenhorn et al. 1992; Hendrickson et al. 
1989; Diamandis et al. 1991). 
Finally, when compared to the conditions used in covalent coupling strategies, 
avidin-based surface engineering of PLA-PEG-biotin has the advantage of 
being rapidly completed in a mild aqueous environment, with simple washing 
and purification steps (Figure 3.2). It therefore may eliminate the potential of 
damage to ligands. In addition, any motif that can-be biotinylated can be 
presented at the surface of PLA-PEG-biotin based biomaterials, and precise 
control over the density of surfaces composed of mixtures of motifs can be 
achieved. PLA-PEG-biotin has been shown to have favourable responses from 
endothelial cells when presenting RGD sequences to the surface using this 
technique (Cannizzaro et al. 1998). This therefore has the potential to be a 
valuable system for the manufacture of tissue engineering scaffolds or 
matrices. The four biotin binding sites in avidin also combines a potentially 
effective method of self-assembling with the advantageous properties of the 
PLA-PEG based systems. 
An important factor in the design of new biomaterials is reproducibility in 
terms of chemical, physical and biological properties. PLA-PEG-biotin can be 
synthesised in two steps: Biotin attachment to bi-functional PEG followed by 
PLA attachment to PEG-Biotin by ring-opening polymerisation of the lactide. 
The polymerisation is possible using two methods; solution polymerisation or 
melt polymerisation. 
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PLA-PEG-biotin surface with biotin 
presented on flexible protein resistant 
PEG chains 
a 
Q®® 
Q nn 
Incubation in aqueous avidin solution 
Avidin 
Wash away excess avidin and incubate with 
biotinylated ligands 
I 
= Biotinylated 
® Ligand 
Figure 3.2 Schematic of surface engineering approach of PLA-PEG-biotin 
adapted from (Patel et al. 1998) 
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Given the vigorous conditions of synthesis, it is essential that the manufacture 
of the polymer does not alter the biotin structure or its molecular recognition. 
Equally, it is important that the incorporation of biotin does not adversely 
affect the physicochemical properties of the polymer. 
1H-NMR is a useful technique for characterising biotin integrity because two- 
dimensional (2D) spectroscopy has been used to assign complete 'H-NMR 
spectra of d-biotin. Surface plasmon resonance (SPR) and fluorescent 
spectroscopy then prove practical in assessing the surface engineering process 
and whether the biotin unit's biological activity is reduced by synthesis. 
3.1.3 End-group effects on bulk properties of polymers. 
The potential for biotin to affect PLA-PEG bulk properties is significant 
because polymer end-groups have been shown to affect the bulk properties of a 
polymer (Kim et al. 1994; Sung et al. 1999; Zhang et al. 2000; Yasugi et al. 
1999; Tracy et al. 1999; Kajiyama et al. 1998; Hirao et al. 1996; Eguiburu et 
al. 1995). An example of this was found in a polypropylene glycol 
- 
polyethylene glycol copolymer where a change from a methoxy-terminated 
end-group to a hydroxyl end-group lead to changes in the glass transition 
temperature ranging from 12°C to 20°C. This was attributed to interactions 
with the hydroxyl end-group and the ether oxygens on the backbone of the 
polymer and end-to-end hydrogen-bonding interactions (Yoon et al. 1997). 
Further examples of changes in thermal properties because of end-group 
hydrogen bonding have been seen with poly (ethyl ethylene-b-ethylene 
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oxide)(PEE-PEO) diblock copolymers with pyridine-benzoic acid end groups, 
which displayed heterodimeric hydrogen bonding. Whilst short blocks of PEO 
did not crystallise out, the binding of the end groups produced PEO blocks long 
enough to be detected by differential scanning calorimetry (DSC) (Zhang and 
Moore 2000). 
The potential for an end-group to change the glass transition temperature is 
important because too low a Tg can produce a material that is too sticky to 
handle and too high a Tg can produce a material that is not easily processed. It 
is therefore important to reproducibly synthesize a material with a suitable Tg. 
For an example, it has been shown that the Tg has a significant effect on 
relaxation behaviour of PDLLA tablets (Steendam et al. 2001). The Tg is also 
important because it is directly related to the degradation properties of the 
polymer. This was illustrated by Li et al who have shown that as PLA 
degrades, the Tg changed from 46.4°C initially, decreasing to 29.2°C after 21 
days (Li and McCarthy 1999) 
Varying the end group of the polymer itself can also alter polymer degradation 
rates. For example autocatalytic degradation due to carboxylic acid groups, 
may be slowed by blocking the end groups. (RothenWeinhold et al. 1997) 
Microparticles made of PLGA with free carboxyl groups at the polymer 
terminus were compared with microparticles with capped PLGA, which had 
ester linkages at the polymer terminus resulting in a more hydrophobic alkyl 
end. Comparing the capped polymer to the uncapped PLG (similar molecular 
weight but different end-group) showed that the uncapped end-group polymer 
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degraded 2-3 fold faster in vitro and 3-4 times faster in vivo than the capped 
polymer. The uncapped PLGA degraded faster than the capped in part because 
it took up water at a faster rate than the capped polymer (Tracy et al. 1999). 
Given that the biotin interaction with avidin involves establishing 36 hydrogen 
bonds (excluding water molecules) and the presence of both ether and ester 
oxygens along the backbone of the polymer, it is feasible that biotin as an end- 
group could influence the bulk properties of PLA-PEG in a similar manner 
(Rosano et al. 1999). Therefore we also undertook a systematic study to assess 
the impact of the biotin end-group on the PLA-PEG. 
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3.2 Experimental Section 
3.2.1 Materials 
a-hydroxy-ca-amine PEG (Mw 3,400) and methoxy-terminated PEG (Mw 
3,000) were purchased from Shearwater Polymers. DL-lactide was purchased 
from Purac and stored at 0°C under nitrogen. N-hydroxy succinimide (NHS) 
biotin was purchased from Pierce & Warriner. Stannous II octanoate [Sn(Oct)2] 
and all solvents were purchased from Sigma/Aldrich (Poole, UK). Stannous II 
octanoate was stored under vacuum and used as received following a nitrogen 
purge and 1H NMR checks for impurities. 
3.2.2 Synthesis of PLA-PEG-biotin 
Synthesis of Biotin-PEG-OH 
a-hydroxy-w-amine PEG (lg) was dissolved into acetonitrile (2m1). Methylene 
chloride (lml) & Et3N (8Oµ1) were added and the mixture then stirred for 1 
minute. After addition of NHS-Biotin (0.250g), the reactants were stirred 
overnight under argon. The reaction was worked-up by the slow addition of 
diethyl ether (40m1) to precipitate the polymer, which were then filtered on a 
Buchner funnel and washed with diethyl ether. The isolated material was then 
dissolved in hot isopropanol (70°C) to give an opaque-cloudy solution. The 
polymer was reprecipitated on cooling; this product was then analysed for 
biotin attachment by 'H-NMR spectroscopy. 
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Removing water impurities and aqueous impurities from Biotin-PEG-OH 
The polymer (350 mg) was dissolved into toluene (70m1) and refluxed with a 
Dean-Stark trap and a condenser. 70% of the toluene was removed by 
distillation. The polymer was isolated on a rotary evaporator. To remove 
residual solvent, the polymer was dried under vacuum (Edwards RV8) for 2 
days. 
Preparation of PLA-PEG-biotin 
The graft polymerisation of lactide on Biotin-PEG-OH by solution 
polymerisation. 
Glassware was silanized by rinsing with a 5% methyltrichlorosilane solution in 
toluene; rinsed with acetone and left overnight to dry at 130°C. A 50m1 round- 
bottom flask was charged with Biotin-PEG-OH (0.35g). Lactide (2g) was 
transferred into the round-bottom flask, diluted with 10m1 toluene, and the 
r round-bottom flask capped and placed in the dessicator. The round-bottom 
flask was then taken out of the dessicator and heated to 60°C until the contents 
went into solution. Sn(Oct)2/toluene (0. ig in iml) was then added and the 
reaction was then brought to reflux at 110°C for 4 hours under argon. 
Following this, the reaction vessel was equipped with a Dean-Stark trap and 
any remaining solvent was removed by vacuum rotary evaporator. The 
remaining viscous material was heated to 140°C; a melt, which was left for one 
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hour under argon. The reaction mixture was allowed to cool after which it was 
dissolved in approximately 10ml dichloromethane. This polymer solution was 
then added drop-wise to a cold stirring solution of 100m1 diethyl ether. The 
final product was isolated by vacuum filtration and lyophilised overnight. 
Approximately 2. Og of white powder was isolated. 
The graft polymerisation of lactide on Biotin-PEG-OH by melt 
polymerisation 
This method was as described for the solution polymerisation with the 
exception that the contents were not diluted with toluene. The round-bottom 
flask with lactide (2g) and Biotin-PEG-OH (0.35g) was sealed under argon and 
heated at 140°C for 16 hours before being reprecipitated as previously 
described. 
3.2.3 Preparation of PLA-PEG by melt and solution polymerisation 
Synthesis as described for PLA-PEG-biotin substituting Biotin-PEG-OH with 
Me-PEG-OH. Synthesis of low-content lactide PLA-PEG-biotin by melt and 
solution polymerisation were completed as described for PLA-PEG-biotin 
using 0.2g lactide. 
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3.3 Instrumentation Methods 
3.3.1 Nuclear magnetic resonance spectroscopy (NMR) 
Proton 1H NMR spectra were recorded on a Bruker ARX-250 spectrometer at 
250MHz. 'H-NMR chemical shifts were measured in parts per million (ppm) 
relative to CHC13 in CDC13 and DMSO in DMSO-d6. 
3.3.2 Gel permeation chromatography (GPC) 
GPC studies were conducted using degassed chloroform as the eluent with a 
sample concentration of 0.2% w/v, an injection volume of l00µ1, columns 
consisting of 2xPlgel 5 µm (300x7.5mm), a flow rate: 1.0 ml/min. Studies were 
carried out at ambient temperature and a pressure of 70 bar. The detector used 
DRI and polystyrene (Easical PS-2) was used to calibrate the system. 
3.3.3 Differential scanning calorimetry (DSC) 
DSC thermograms were recorded with a Perkin Elmer CCA7 analyser and a 
Perkin Elmer TAC 7/DX. The heating rate was 10°C a minute with a 
quenching rate of 200°C a minute. Values of glass transition temperatures (Tg) 
were taken from the midpoint of the transition region. 
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3.3.4 Surface plasmon resonance (SPR) 
The SPR equipment (Ortho Clinical Diagnostics, Chalfont, St-Giles, UK) 
employs a Kretschmann configuration with a monochromatic laser source of 
780nm wavelength. The glass slides used had a 50nm silver layer on one side. 
These were coated with samples from a 3mg/mL chloroform solution spun-cast 
with 10011L at 2000 rpm. This resulted in films that gave time-dependent SPR 
angle (OsPR)(in millidegrees mDA) which is the angle at which the minimum in 
light intensity occurs. Avidin (Sigma, Poole, UK) was made up to 5x 10'7 M in 
dibasic phosphate buffer (10 mM, pH 7.4), which also acted as the medium for 
washing. The flow rate was 0.24 mUmin and binding of avidin was determined 
over 1000 second time periods. Injection of the avidin solution took place 
approximately 100 seconds after the start of each run. Results were taken from 
at least 8 repeats 
3.3.5 Fluorescent spectroscopy studies using the 12-4'- 
hydroxyazobenzene benzoic acid] (HABA)/avidin reagent. 
Spectroscopy studies were completed on a Beckman DU-600 spectrometer at a 
fixed wavelength of 500 nm at 37°C. The average read time was 0.5 seconds 
and the read mode [Abs]. Three blanks were read followed by three readings of 
the HABA/avidin in lml cuvettes. Each polymer sample was recorded 3 times 
over a subset of 4 repeats. The assay was completed by measuring the 
absorbance of the avidin-HABA complex at Asoo before and after it has been 
placed over a film of PLA-PEG-biotin of known surface area. The absorption 
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decreases proportionately to the biotin present on the surface because biotin 
displaces HABA due to its higher affinity for avidin. The change in absorbance 
can then be used to calculate the amount of biotin present (Green et al. 1965). 
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3.4 Results and Discussion 
The attachment of biotin to H2N-PEG-OH was achieved through N-hydroxy- 
succinimide chemistry (Figure 3.3). The graft polymerisation of lactide to the 
HO-PEG-biotin proceeds through a ring-opening polymerisation mediated by 
the Sn(Oct)2 complex suggested by Kricheldorf (Kricheldorf et al. 1995). 
Sn(Oct)2 has energetically favourable free d orbitals and can thus act as trans- 
esterification catalysts for alcohols and esters including lactones. (Kricheldorf 
et al. 1995) The octoate groups act mainly as mono-dentate ligands in 
Sn(Oct)2. In consequence, there are three sp3d2 orbitals free. The high lewis 
acidity leads to the need for another ligand so that Sn(Oct)2 can form a more 
stable tetrahedral or quadratic configuration of four occupied orbitals. This 
ligand is the OH group of PEG-Biotin. 
The first step involves a co-ordination between the catalyst and the OH- end 
group of the PEG-Biotin. Binding of the lactone then catalyses the reaction 
because complexation of the lactone polarises its carbonyl group (Figure 3.3). 
Sn(Oct)2 also forms strong complexes with water which means that any water 
impurities present would lead to homo-polymerisation of lactide as illustrated 
in Chapter 1. For this reason it was very important to silanise all glassware and 
dry all the reagents especially hydrophilic PEG which has such a great affinity 
for water. 
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Step 1. Biotin attachment to PEG 
HO 
III 
HO-PEG-N-C-(CH2)5-Biotin 
Step 2. Graft polymerisation of lactide to HO-PEG-Biotin 
H 
Oct Sn------O-PEG-Biotin HI Me e 
Oct2Sn * O-CH-CO-O-CH-CO-O-PEG-Biotin 
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0 
lactide 
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Figure 3.3 Schematic of synthesis of PLA-PEG-biotin 
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The calculated DPp1, values were found to be in good agreement with 
theoretical values deduced from the LA/EG ratio in the feed indicating a high 
yield from the polymerisation (Table 3.3). Further confirmation of this is that 
no monomer impurity can be detected by IH NMR, where the NMR shift of the 
monomer lactide to the poly (lactic acid) has the quartet shift from 5-5.1ppm to 
5.1-5.3ppm and the doublet shift from 1.7-1.75ppm to 1.5-1.6ppm (Figure 3.4). 
Identification of pure PLA-PEG without any PLA homopolymer is seen 
through GPC spectra. For an example when water impurities were present in a 
PLA-PEG-biotin synthesis, this resulted in a bimodal peak, one of which was 
the PLA homopolymer and the other belonging to the PLA-PEG-biotin 
copolymer. A single peak therefore indicated that a pure polymer had been 
achieved. NMR analysis on the final product showed no incorporation of 
octoate end-groups and GPC measurements display a relatively broad 
molecular weight distribution (Table 3.3). 
3.4.1 Evidence of attachment of biotin. 
Analysis of HO-PEG-Biotin by 'H-NMR spectroscopy showed the appearance 
of a triplet at 2.05ppm that can be assigned to the methylene from the biotin 
chain alpha to the amide and the appearance of a broad singlet belonging to the 
free amido proton at 7.85 ppm. These signals were not present on the NMR 
spectra of NHS-Biotin. The biotin group was identified through the two 
methine protons (H-3, H-4) from the cyclic biotin structure at 4.3 and 4.2ppm 
and two urea protons (H-1', H-3') from the cyclic biotin structure at 6.45, 
6.35ppm (Bates and Rosenblum 1985; Tonan et al. 1998). 
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Polymer LA/ 
EG 
In 
feed 
LAS 
EG° 
In 
product 
DP 
PEOb 
DP 
PI,, eb 
Mw Mn' Tg 
(°C) 
1H NMR shifts (ppm) 
CDC13 as ref. 
CH CH2 CH3 
(PLA) (PEG) (PLA) 
PLA-PEG- 6.1 5.5 76 418 22680 33440 16 1.56 3.53 5.24 
biotin by melt 
polymerisation 
PLA-PEG- 6.2 5.3 76 403 22210 32290 17 1.53 3.51 5.22 
biotin by 
solution 
polymerisation 
PLA-PEG by 6.2 6.8 68 462 27440 36260 14 1.55 3.51 5.20 
melt 
polymerisation 
PLA-PEG by 6.1 5.8 68 394 23690 31360 16 1.54 3.52 5.23 
solution 
polymerisation 
' Determined by using the integration ratio of resonances due to PEG blocks at 3.5ppm (-0- 
CH2-CH2) and to PLA blocks at 1.55ppm (CH3) in the IH NMR spectra. bDPpEG 
-B= 3350/44 = 
76 and DPPEG = 3000/44 = 68, DPpLA = DPPEG x (LA/EG). `Mn = 44 x DPPEO + 72 x DPPLA 
Table 3.3 Bulk properties of PLA-PEG and PLA-PEG-biotin by 1H-NMR, 
GPC and DSC analysis. 
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Quartet from D form of lactic acid 
and quartet from L form of lactide 
within the PLA-PEG copolymer. 
ýý 
Quartet from 
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Figure 3.4 Lactide monomer impurity detection in PLA-PEG using 1H NMR. 
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In NMR spectras of PLA-PEG-biotin (Mw 22210), biotin signals could not be 
seen as the signal from the PLA overwhelmed the biotin signal. (CH; 1.53 
ppm, CH3; 5.22 ppm). For this reason a low-content lactide, PLA-PEG-biotin 
was synthesised (0.2g lactide, 0.35g PEG-Biotin). 1H-NMR studies on the low- 
content lactide PLA-PEG-biotin by solution and melt polymerisation showed 
that biotin integrity and attachment was maintained after graft polymerisation 
of lactide to the PEG-biotin, with the biotin protons (H-3, H-4, H-1', H-3') at 
4.2,4.3,6.35 and 6.45ppm and the amide bond at 7.85ppm still clearly 
detectable (Figure 3.5). However due to degeneracy in the 1.53ppm and the 
5.22ppm region from the PLA signals, SPR and fluorescent spectroscopy using 
the HABA/avidin complex were necessary to confirm complete biotin binding 
integrity (Table 3.4). Assessment was also undertaken to resolve whether the 
route of synthesis showed any effect on the biotin attachment or its binding 
capabilities, given that melt polymerisation of this polymer had been 
synthesised at a temperature 30°C higher than solution polymerisation. 
SPR analysis measured avidin binding with the PLA-PEG-biotin and PLA- 
PEG by both synthetic routes. The increase in 4SPR from the injection of avidin 
for the melt polymerised PLA-PEG was 40.90 ± 5.07 mDA and for the solution 
polymerised PLA-PEG was 42.75 ± 6.48 mDA. The PLA-PEG-biotin by melt 
and solution polymerisation after injection of avidin gave spa shifts of 170.46 
± 4.89 mDA and 181.58 ± 12.19 mDA respectively. There is a clear difference 
between the PLA-PEG and the PLA-PEG-biotin (Figure 3.6) that is consistent 
with previous work (Black et al. 1999). 
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Polymer SPR shifts Absorbance value Absorbance value 
(mDA) after addition to after addition to 
polymer film in polymer film in 
buffer DME tissue 
culture media 
PLA-PEG-biotin by 170.46 ± 19.57 1.056 ± 0.002 1.3911 ± 0.006 
melt polymerisation 
PLA-PEG-biotin by 181.58 ± 12.19 1.052 ± 0.003 1.3749 ± 0.006 
solution polymerisation 
PLA-PEG by melt 40.90 ± 5.07 1.111 ± 0.010 1.4219 ± 0.005 
polymerisation. 
PLA-PEG by solution 42.75 ± 6.48 1.105 ± 0.003 1.4197 ± 0.008 
polymerisation 
Table 3.4 Surface analysis of biotin integrity and binding capabilities by 
SPR and fluorescent spectroscopy with the HABA/avidin complex. 
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Figure 3.6 SPR traces measuring avidin immobilisation of PLA-PEG and 
PLA-PEG-biotin by melt and solution polymerisation. 
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The shifts noted with the PLA-PEG surface can be attributed to non-specific 
interactions, which have been well characterised by Green et al (Green et al. 
1997; Green et al. 1999). There was no significant statistical difference in 
comparisons of polymers synthesised by either melt or solution polymerisation. 
Fluorescent spectroscopy studies using the HABA/avidin complex supported 
SPR data with no decrease in absorbance for the PLA-PEG and a decrease 
from 1.100 ± 0.004 to 1.052 (equivalent to 625,260 molecules of biotin/µm2) ± 
0.003 and 1.056 (539,010 molecules of biotin/µm2) ± 0.002 for PLA-PEG- 
biotin by solution polymerisation and PLA-PEG-biotin by melt polymerisation 
respectively. 
A modification of the HABA/Avidin protocol to assess PLA-PEG-biotin 
binding under cell culture conditions was to prepare the HABA/Avidin reagent 
in Dulbecco's modified eagle medium (DMEM) with high glucose, 1- 
glutamine, HEPES buffer and pyrodoxine hydrochloride. The effect of the 
media was to increase the absorbance from 1.100 ± 0.004 to 1.4254: 0.013. 
This value did not decrease when HABA/Avidin reagent in DMEM was added 
to a film of PLA-PEG. A decrease was, however, detected from 1.447 
-4- 0.0026 
to 1.3911 ± 0.0059 (625,190 molecules of biotin/µm) for a film of PLA-PEG- 
biotin by solution polymerisation and a decrease from 1.4190 ± 0.0055 to 
1.3749 ± 0.0069 (514,670 molecules of biotin/µm2) for a film of PLA-PEG- 
biotin by melt polymerisation. 
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The results show clear evidence of HABA displacement with avidin by the 
biotin moieties with the PLA-PEG-biotin but no displacement with the PLA- 
PEG, which is consistent with expectations. This in conjunction with SPR data, 
which also showed clear differences in OSPR shifts between the PLA-PEG- 
biotin and the PLA-PEG, suggests that biotin structural integrity had been 
maintained together with binding capabilities during synthesis. 
3.4.2 Effect of biotin on bulk properties of PLA-PEG 
Having shown that the biotin unit was intact, bulk/thermal property analysis 
through comparisons of PLA-PEG and PLA-PEG-biotin by melt and solution 
polymerisation was undertaken to see the effect biotin attachment had on the 
PLA-PEG bulk properties. NMR spectroscopy and GPC studies were 
completed to ensure that the structural characteristics and molecular weight of 
the polymer were consistent so that any change in thermal properties were not 
due to variations other than the end-group. Analysis showed very little 
difference when characterisation was completed by NMR spectroscopy and 
GPC (Table 3.3). NMR spectroscopy analysis gave similar integral ratios of 
PLA to PEG for all four polymers with characteristic peaks for PLA being a 
doublet (CH) at 1.53 ppm and a quartet (CH3) at 5.22 ppm and a singlet for 
PEG (CH2) at 3.51 ppm. GPC studies gave a mean molecular weight of 24000 
± 2370 confirming that molecular weight differences should not be responsible 
for any large differences in bulk properties. 
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DSC data showed that the addition of PEG/PEG-biotin to the PDLLA results in 
a drop in the glass transition temperature from between 44-50°C for pure 
PDLLA to 14-17°C for the PLA-PEG/PLA-PEG-biotin copolymer. The 
monophasic profile displayed by the polymers was constitent with reports that 
block copolymers derived from D, L-lactide are usually monophasic and do not 
show first-order phase transitions, because more or less random sequences of D 
and L lactyl units do not crystallize (Kricheldorf and Meierhaack 1993). There 
was little difference in thermal properties between the biotinylated and non- 
biotinylated PLA-PEG and the melt and solution polymerised products 
suggesting that the biotin end-group does not change the bulk properties of the 
polymer (Figure 3.7). This was consistent with the work carried out by 
Kricheldorf et al. on the variation of end-groups and synthesis of block 
copolymers with PEG by anionic polymerisation of lactide where DSC studies 
showed that thermal properties are predominantly dependent on the PLA: PEG 
ratio and not the end-group [Kricheldorf et al. 1993; Kricheldorf et al. 1999; 
Caibao et al. 1996). 
k 
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Scan Rate 10°C /Minute 
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Figure 3.7 DSC thermograms for PLA-PEG-biotin and PLA-PEG by melt 
and solution polymerisation 
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3.5 Conclusion 
The synthesis of a novel biomaterial that can integrate biological activity into 
its surface chemistries is described. PLA-PEG-biotin combines the benefits of 
PLA-PEG based copolymer systems with the advantages of the universal 
avidin-biotin linkage system. 
It is necessary that in the synthesis of these materials, such as PLA-PEG-biotin, 
the integrity of the functionalised end-group be maintained without affecting 
the bulk properties. Here it has been shown that the synthesis of PLA-PEG- 
biotin can be carried out without any degradation to the biotin end-group. 'H- 
NMR spectroscopic analysis has confirmed biotin attachment and integrity. 
SPR analysis and fluorescent spectroscopy studies with the HABA/avidin 
complex have shown that biotin's binding abilities have not been impaired 
during synthesis by either melt or solution polymerisation. 
'H-NMR, GPC and DSC characterisation shows there is no significant effect 
on bulk properties induced by the biotin end-group. This indicates that PLA- 
PEG-biotin can be repeatably synthesised with predictable and controllable 
bulk properties. PLA-PEG-biotin therefore has significant potential for 
widespread use in drug delivery and diagnostic applications. Furthermore, 
evidence that the biotin unit and its binding properties are intact and have not 
compromised the bulk properties of the polymer, provides a material that can 
form the foundation of our proposed self-assembling porous scaffold. 
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CHAPTER 4 
INTERACTIONS OF FIBROBLASTS AND ENDOTHELIAL 
CELLS WITH DEFINED PORE FEATURES 
The potential for controllable porosity by the proposed self-assembling 
scaffold is a considerable advantage over other injectable in situ transforming 
biomaterials because non-porous materials limit tissue formation and 
vascularisation to the barrier of diffusion to signaling and nutrient molecules. 
Before progressing onto the manufacture, characterisation and assessment of 
our scaffold in Chapter 5 and 6, it is important to have a fundamental 
understanding of the pore-cell interaction if scaffold characteristics are to be 
optimised. Chapter 4 introduces the concepts of cell behaviour over defined 
features, the methods that are currently used to produce these features and 
concludes with a systematic study of two model cell types over a series of 
defined pore features fabricated using photolithographic techniques. 
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4.1 Introduction 
The use of biodegradable polymer scaffolds as templates for tissue engineering 
has been described for a number of tissue types, including cartilage, liver and 
nervous tissue (Den Dunnen et al. 1993; Bellamkonda and Aebischer 1994; 
Baldwin and Saltzman 1996; Hutmacher 2000). Within these scaffolds, the 
seeded cells encounter a high surface area formed by the polymer. This surface 
is convoluted to form a three-dimensional structure containing many pores 
(Wake et al. 1994; Kaufmann et al. 1997; Athanasiou et al. 1998; Evans et al. 
1999). The success of the tissue engineering is dependent on the migration of 
cells through this porous environment and the maintenance of nutrient 
diffusion throughout the scaffold after cell colonisation. Ideally, after seeding 
the cell population should be able to migrate through the scaffold and some 
pores should remain open to nutrient diffusion as the tissue forms. Further 
information on the influence of porosity in tissue engineering scaffolds can be 
found in Chapter 1. 
To study the effect of pore diameter on cell migration and morphology we have 
used microfabrication to form surfaces with defined porosities enabling the 
study of cell behaviour over these defined topographical features. Two cell 
types have been chosen for these studies, 3T3 fibroblasts and bovine aortic 
endothelial cells (BAECs). Cell type choice was made due to the different 
behaviour of these cells during tissue formation in vivo. Fibroblasts tend to fill 
spaces within tissues and form extracellular matrix, whilst in endothelial, cells 
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form into tubular architectures in which the integrity of a central lumen is 
essential to blood vessel function. 
4.1.1 The formation of topographical features using photolithography 
The advances in microfabrication technologies in the microelectronics industry 
have led to the potential to study cell behaviour over defined topographical 
features. The most recent approaches have involved the process of 
photolithography (Clark et al. 1991). Using current silicon chip technologies, a 
chrome mask can be designed by computer-aided design and transferred and 
written by electron beam lithography (typically a high voltage 0.1 micron 
diameter beam containing 1 nA of 20kV over area to be written) (Lawes 1994). 
The mask produced can then be used to pattern specific designs onto silicon 
wafers. 
A photoresist is used to protect the silicon substrate and exposure to UV light 
under the designed mask deprotects specified regions for etching. Currently the 
most effective method for microfabrication is plasma etching (reactive ion 
etching) because of its ability to etch anisotropically and thus produce deeper 
microstructure with higher aspect ratios (Lawes 1994; Lawes 1996). Various 
biocompatible surfaces such as silicon nitride can be etched by selecting the 
ions specific to the substrate (Clark et al. 1991; Kue et al. 1999). The etching 
is achieved by the bombardment of ions in a vacuum. While ions of non- 
reactive species such as argon will erode most materials, the resultant profiles 
of the ridges in the etched material are rarely vertical (Lawes 1994). The use of 
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ions that react chemically with the material is preferred e. g. fluorine ions attack 
silica glass or oxygen ions etch polymeric plastic materials, essentially by 
burning. It is not necessary to use the pure gas in forming the ions; it is 
significantly safer to use for an example, chlorine formed by a discharge in 
gaseous silicon tetrachloride. The desired ions are usually formed by a 
discharge in a low-pressure gas and are accelerated by an electric field towards 
the specimen to be etched. In the reactive ion etching schematic shown in 
Figure 4.1, the ions are formed in a rf discharge, and as the ions travel much 
more slowly than the electrons, a d. c. electric field is built up which accelerates 
the ions towards the substrate. This electric field is of the order of 400 to 4000 
V which is not enough to cause implantation of the ions into the substrate 
(Clark et al. 1991; Curtis 1994; Lawes 1994; Lawes 1996). It is rare that the 
pattern in resist can be used directly; normally it must be transferred into the 
desired material. This can be done either using additive or subtractive 
processing. In additive processing the relief pattern in the resist is used as a 
stencil; material is superimposed on the substrate in areas that are not protected 
by the resist pattern. This can be done by overcoating with vacuum 
evaporation, for example, the whole surface with the desired material and 
immersing the specimen in a flowing stream of solvent that washes away the 
resist leaving the overcoated material only on the substrate. Thus, the resist is 
used to protect the regions of the underlying substrate that are not to be etched. 
Both positive and negative acting resists may be used and thus, by careful 
design of the mask pattern, a wide variety of microholes, microchannels, 
micropillars etc may be fabricated with submicron dimensions. 
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Vacuum 
envelope 
rf 
rf discharge 
- 
Material to 
be etched 
Figure 4.1 Schematic of reactive ion etching machine 
Strong electric field in 
this space accelerates 
ion toward specimin 
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Wet chemical etches are not always suitable in nanofabrication as they are 
normally isotropic in their action making it difficult to make high aspect ratio 
structures and it is difficult to obtain uniform etching at below 100 nm line 
widths (Curtis and Clark 1990; Clark et al. 1991; Lawes 1996; Curtis and 
Wilkinson 1997; Curtis and Wilkinson 2001). 
4.1.2 Effect of cell behaviour over topographical features 
It has been widely reported that a change in surface topography can influence 
cell behaviour substantially. Table 4.1 provides some examples of the wide 
variety of features that have been produced and the behaviour of cells over 
them. Micron-scale roughness has been shown to modify cellular responses in 
cell culture and to modify biocompatibility and tissue attachment significantly 
(Vonrecum and Vankooten 1995). This was demonstrated in a comparative 
study concerning textured and smooth polytetrafluroethylene (PTFE), where 
exudates obtained from fibroblasts cultured on textured PTFE contained 
significantly more growth and attachment-promoting activity than those 
obtained from fibroblasts cultured on smooth PTFE. 
Cell spreading and cell shape and their effects on cell growth and cell function 
have also been shown to be dependent on surface morphology (Singhvi et al. 
1994; Singhvi et al. 1994). For an example, Cook et al cultured MDCK cells in 
vitro on microporous membranes and showed that the differentiated state of 
MDCK cells could be regulated by the microporosity of the surface (Cook et 
al. 1989). 
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One proposal has been that topography affects cell behaviour by altering the 
ability of the extra-cellular matrix (ECM) to absorb to the surface (Meyle et al. 
1994; Vonrecum and Vankooten 1995). Topographical features have been 
shown to orient cells in a phenomenon known as "contact guidance" (Brunette 
1986; Brunette 1986; Clark et al. 1991; Clark 1994; Curtis 1994; Meyle et al. 
1994; Denbraber et al. 1995; Flemming et al. 1999). Brunette et al for an 
example showed that major grooves interfered with the cells ability to form 
long linear cytoskeletal elements, such as microtubules or microfilaments, in 
the direction of the minor grooves and that the cells tended therefore to be 
polarized so that they were aligned with the major grooves. It has been 
suggested that features that involve a change in the direction from one surface 
configuration into another as produced by hills, pits, valleys, grooves, or edges 
extending out into the main plane or an edge where two planes meet may be 
seen as discontinuities (Vonrecum and Vankooten 1995). Cells attach to a 
surface by a number of contacts including podosomes, dot contacts, point 
contacts and focal contacts (Meyle et al. 1994). These focal adhesions consist 
of a cluster of ECM-bound integrins that act as a membrane attachment for the 
actin fibrils inside a cell (Ruoslahti and Obrink 1996; Ruoslahti 1997). There is 
a great deal of evidence to suggest that there is a concentration of these focal 
adhesion points at discontinuities (Brunette 1986; Curtis and Clark 1990; 
Curtis and Wilkinson 1997; Flemming et al. 1999). Intracellular proteins 
involved in the focal adhesions crosslink the actin micro-filaments, whose 
structure determines cell shape maintenance (Vonrecum and Vankooten 1995). 
Integrins link the external ECM to the intracellular actin cytoskeleton and it is 
the presence of the concentrated actin at the discontinuities as detected by 
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phalloidin staining that confirms the theory of focal adhesion points being 
formed at discontinuities (Brunette 1986; Curtis and Clark 1990; Vonrecum 
and Vankooten 1995; Ruoslahti and Obrink 1996; Curtis and Wilkinson 1997; 
Ruoslahti 1997; Flemming et al. 1999). 
There are a number of factors involved in the behaviour of cells over 
topographical features (Clark 1994). Cell density has been shown to have a 
significant role in the behaviour of cells over a defined surface. When BHK 
(fibroblastic) cells were compared directly to MDCK (epithelial) cells, MDCK 
cells in co-culture were often unaffected by topographical features that would 
strongly orientate single MDCK and BHK cells (Curtis and Clark 1990). 
Where topographical features are on the nanometre scale, cell-cell interactions 
have in fact been found to be the more dominant factor in determining cell 
guidance (Clark et al. 1991). There are also clear differences in behaviour 
between different cell types (Clark 1994; Flemming et al. 1999). This may be 
attributed to different amounts of actin monomer available in different cell 
types. A cell with less actin monomer will use the majority of this in forming a 
polymer once in contact with a discontinuity, thus reducing further movement 
or spreading of the cell and limiting its movement to around the discontinuity 
(Curtis and Clark 1990). Some cell types may display co-operative behaviour 
with topographical features. This has been demonstrated when cells migrating 
along fibres attached to other cells to form "sail sheets" to get from one 
topographical feature to another where the depth was too great (Curtis and 
Clark 1990). 
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4.2 Materials and Method 
4.2.1 Silicon Nitride Template Manufacture 
Porous silicon nitride membranes were manufactured using a multistage 
process (Figure 4.2). Double side polished silicon wafers of 300 microns thick 
were cleaned and coated with low stress silicon nitride using low-pressure 
chemical vapour deposition (LPCVD). The surface topography design (Figure 
4.3) was written to an electron beam pattern generator (Ebeam) and then 
transferred to two chrome masks, to define the back etch mask and the pore 
size and layout. Silicon wafers coated on both sides with silicon nitride were 
dehydrated at 150°C for 30 minutes. On cooling these were coated with 
hexamethyldisilizane (HMDS) as an adhesion promoter. The back-etching of 
the wafer was achieved as follows. One side of the wafer was spin coated with 
250 microlitres photoresist (AZ5214E) for 60 seconds at 3000 rpm. After a 
solvent bake at 100°C for 90 seconds, the wafer was exposed to UV light from 
a mercury vapour lamp. The exposure energy was 100mJcm 2. The exposed 
resist was developed in a 4: 1 mixture of de-ionised water: AZ-400K developer, 
rinsed with de-ionised water and then spin dried with a nitrogen purge. The 
substrate was then hard-baked for 30 minutes at 120°C. An oxygen plasma 
descum was used to remove organic residues from the exposed nitride surface. 
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1. Formation of underside support 2. Formation of micropores 
Expose photoresist coated silicon Expose other side of silicon nitride wafer coated 
nitride wafer with mask I (back etch) with photoresist with mask 2 (pore etch) 
Mask I for back etch Mask 2 for pore etch 
Silicon Nitride Silicon Nitride 
Silicon wafer Silicon wafer 
Silicon Nitride Silicon Nitride 
1 Reactive ion etching 
1 Wet chemical processing 
Rcacti, c ion etching 
Microscopy image of 
section of 10 micron pores 
in one grid of '8 "8 pores. 
Figure 4.2. Schematic of pore template manufacture. 
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The oxygen plasma was achieved with a flow rate of 35 standard cubic 
centimetres (SCCM) of electronic grade oxygen, a process pressure of 200 
milliTorr, and a Radio Frequency plasma power of 100 Watts at 13.65 MHz for 
a duration of 0.7 minutes. Reactive ion etching of the silicon nitride was 
carried out in a fluorine-based plasma. The process conditions were 35 SCCM 
of CHF3,5 SCCM of 02 at a pressure of 100 mTorr, and power of 150 watts 
for 15 minutes. An oxygen plasma resist strip at 35 SCCM 02 (200 millitore, 
100 watts) for 15 minutes ensured surface chemistry and topography would be 
the same and this was confirmed by a Tencor P2 long scan profiler. After 
cleaning and drying in nitrogen, the substrate was back etched using 45% 
potassium hydroxide (KOH) in de-ionised water. To etch the pores onto the 
silicon nitride wafer, the back-etched substrates were coated with a HMDS 
adhesion promoter at 150°C and then coated with photoresist (AZ5214E). The 
substrate was then exposed to UV light under the mask with the pore designs. 
Reactive ion etching and plasma cleaning were carried out under identical 
conditions, but on the other side of the wafer. Once the pores were defined the 
wafer was cleaned using a photoresist stripper (1-amino-propan-2-ol, AZ-100 
remover), rinse in deionised water and then dried. 
4.2.2 Cell Culture 
3T3 fibroblasts (ATCC) and bovine aortic endothelial cells (ECACC) were 
cultured in DMEM supplemented with 10% foetal calf serum, 2 mM L- 
glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 0.25 gg/ml 
amphotericin B. Cell cultures were incubated at 37°C in a 5% CO2 enriched 
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atmosphere. Silicon nitride substrates were coated for 24 hours with 10mg/ml 
fibronectin dissolved in de-ionised water. Substrates were washed three times 
with de-ionised water prior to seeding with cells. A cell seeding density of 
7000 cells/cm2 was used in all studies. 
3T3 fibroblasts (ATCC) and bovine aortic endothelial cells (ECACC) were co- 
cultured in DMEM supplemented with 10% foetal calf serum, 2 mM L- 
glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 0.25 pg/ml 
amphotericin B. Cell cultures were incubated at 37°C in a 5% CO2 enriched 
atmosphere. Co-culture studies were carried out by seeding substrates with 
3500 cells/cm2 of each cell type in a mixed suspension. 
The fibroblasts were treated with using a green chloromethyl derivative of a 
fluorescein diacetate derivative (CellTrackerTM, Molecular Probes) to identify 
the individual cell types in cell coverage calculations. CellTrackerTM passes 
freely through cell membranes, but once inside the cell undergoes a glutathione 
S-transferase-mediated reaction, producing a cell-impermeant florescent dye- 
thioether adduct reaction product. Excess unconjugated reagent passively 
diffuses to the extracellular medium. 
Studies with CellTrackerTM were completed by adding 11 µl of DMSO 
(Aldrich) and 1 ml of media to 50 µg of CellTrackerTM. After mixing and 
syringe filtering, this was added to a further 1 lml of media and placed over the 
cell culture for 30 minutes after which fresh media was added. 
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For phalloidin staining of cytoplasmic actin filaments. Cells were fixed in 2% 
glutaraldehyde for 24 hours, washed with phosphate buffered saline. 0.1% 
Triton-X was added for 10 minutes; removed and washed. Phalloidin (250 
µg/ml) in PBS was then incubated with cells for 30 minutes. The samples were 
washed several times in phosphate buffered saline. 
4.2.3 Microscopy and Time-lapse studies: 
Phase contrast images were taken on an optical microscope (Leica DMIRB) 
attached to a Leica Q500 IW using a colour video camera (JVC TK-C1380). 
Time-lapse studies were captured on the optical microscope in an 
environmental chamber (Leica) at 37.1°C (Solent Scientific Incubator 
Temperature) in a 5% CO2 enriched environment (Linkam CO 102). Images 
were taken every 10 minutes over 24 to 48 hour periods. Cell coverage 
calculations were made using Leica Qwin Software. Florescent images were 
taken using an absorbance/emission setting of 492-nm/516 nm. 
4.2.4 Quantification: 
Each set of pores, of a defined size, are set in an 8 by 8 array in a window of 
3.2mm by 3.2 mm. Each pore is separated by 320 µm in both the x and y-axis. 
Differing windows contains set of pores of differing sizes ranging from 5 
microns to 100 microns with single pores up to 160 microns in individual 
windows. Assessments of cell behaviour for quantitative studies were 
completed by defining cell interaction with the pores into two classifications: 
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(1) uncovered and (2) covered. Measurements were taken on every pore within 
a window at set intervals of 4 hours, 24 hours, 48 hours and 72 hours. Further 
measurements were made every 24 hours as necessary. Repeat studies were 
then carried out to ensure reproducibility in the results. Statistical analysis of 
the cell behaviour was calculated using one-way analysis of variance 
(ANOVA) with a Tukey post-test for the purposes of comparing pairs of group 
means, from data at each time point. 
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4.3 Results and Discussion: 
4.3.1 Microfabrication of defined pore features 
The study of cells over defined pores is important because porosity has been 
shown to have significant impact on the success of polymer scaffolds in tissue 
engineering. Two cell types are commonly involved in the vascularization of 
scaffolds. These are endothelial type cells for blood vessel supply to the 
scaffold and fibroblastic type cells, which invade the pores within the scaffold. 
Predicting the behaviour of these cell types is critical because scaffolds 
invaded with vascularized fibrous tissue has been shown to both increase 
viability of cells such as hepatocytes and decrease porosity of the scaffold 
(Mikos et al. 1993) (Mooney et al. 1997). On this basis, we chose bovine aortic 
endothelial cells (BAECs) and 3T3 fibroblasts as our model cell types and 
assessed these under single and co-culture conditions. 
The first stage in our experimental design was the manufacture and preparation 
of our pore features. As described in Chapter 1, pore size and structure is the 
predominant factor in determining cell infiltration rates and vascularization 
ability of scaffolds for tissue engineering. These pores vary in size but tend to 
be between 5 and 100 µm with an optimum porosity having been described at 
approximately 60 µm (Clowes et al. 1986; Clowes et al. 1987; Salzmann et al. 
1997; Sharkawy et al. 1997). For this reason, a range of pores from 5 to 100 
µm was manufactured. 
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Pore templates were manufactured using a multistage photolithographic 
process as described in the methods section. The choice of silicon nitride as a 
substrate was made because it was able to undergo the photolithographic 
processes and had been shown to be non-toxic to cell cultures (Kue et al. 
1999). Plasma ion etching was used to etch the pores into substrate as this 
provided pores with the highest aspect ratio. Given that changes in surface 
energy had been shown to have some effect on cell behaviour, all templates 
were plasma oxygen etched in order to keep surface chemistry and topography 
the same (Denbraber et al. 1995). A Tencor P2 long scan profiler confirmed 
that the surface topography around the pores was flat. It has also been 
hypothesized that the behaviour of cells over various topographies is due to the 
ability of a surface to absorb extra-cellular matrix and this ability is altered 
over various topographical features. (Vonrecum and Vankooten 1995) For this 
reason, all samples were coated with a fibronectin solution over a 24-hour 
period, which in conjunction with the otherwise flat surface should have 
reduced ECM uncertainties around the pore features. 
Each individual pore was assessed before use. As shown in Figure 4.4, a 
number of pores were found over/underexposed, resulting in damaged pores or 
pores that had not fully formed. Such pores often left a trace of lithographic 
material from the washing procedure. These damaged pore features were then 
omitted from cell culture studies. 
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Figure 4.4 Phase contrast microscopy images showing: A/C) overexposed 
damaged 100 µm pores, B) Underexposed 100 µm pore in which pore has not 
fully formed and D) overexposed 60 pm pores. 
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The next stage was to determine an optimal cell seeding density for a short 3- 
day study that could assess cell behaviour over pore features from low cell 
populations to high populations. A range of seeding densities from 2000 to 
7000 cells/cm2 was tested on silicon nitride samples. As seen in Figure 4.5, 
7000 cells/cm2 was found to be optimal seeding density for fibroblasts, 
reaching confluence by 72 hours. Whilst, BAECs had a slower proliferation 
rate, taking 120 hours to reach confluence. It was decided for consistency that a 
seeding density of 7000 cells/cm2 would also be used for endothelial cells and 
that these studies would be carried out over a longer 5-day period. 
For co-culture studies, each cell type was seeded at 3500 cells/cm2 to make a 
total 7000 cells/cm2 seeding density. In the early stages of co-culture, the 
morphology of fibroblasts and BAECs were found to be quite similar. To 
differentiate between the two cell types, fibroblasts were stained with 
Celltracker'. As illustrated in Figure 4.6, fibroblasts with spread morphology 
could be observed and the outlines of pores could be seen, thus allowing pore- 
cell measurements to be made. Measurements were made using light 
microscopy where both cell types could be observed and then again using 
fluorescent microscopy where fibroblasts alone could be seen. The difference 
in the measurements was then assumed to be due to BAEC-pore interactions. 
Finally, to prove that cells were covering the pores and not touching the tissue 
culture plastic below the pore features; pores covered with cells were observed 
by light microscopy and then the tissue culture plastic below them was 
focussed on. 
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Figure 4.5 Phase contrast microscopy images for determination of optimum 
cell seeding density. 
1. Seeding at 3500 cells/cm2 2. Seeding at 7000 cells/cm2 
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Figure 4.6 Fluorescent microscopy images of fibroblasts stained with 
CellTrackerTM showing proliferation over a 48-hour period on silicon nitride 
samples 
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For an example, in Figure 4.7, it can be seen that no cells are present on the 
TCP below a 160 µm pore covered with fibroblasts. Furthermore, in silicon 
. 
nitride samples that were damaged during experiments, it was observed that 
fibroblasts could not proliferate or spread beyond the boundaries of the edges 
of the cracked silicon nitride. 
4.3.2 Endothelial cells 
The endothelial cell population reached maximum cell coverage of the silicon 
substrate after 120 hours of culturing on the samples. As shown in Figure 4.8, 
the endothelial cells did not cover any part of a pore of 80 or 90 µm diameter at 
any time point. Even at the 120-hour point, when the rest of surface was 
essentially entirely covered, the 80 and 90 µm pores were totally uncovered. 
As the pore diameter was decreased from 60 to 30 µm, the number of pores 
that were partially or completely covered by an endothelial cell increased. 
Considering the 30 µm pores, the probability that a pore was covered or 
partially covered was related directly to the total pore coverage (Figure 4.8). In 
comparison, the extent of pore coverage for 40,50 and 60 µm pore diameters 
was lower than the overall substrate cell coverage. At pore diameters of less 
than 30 µm, the endothelial cells are able to cover the pores to the same extent 
as the rest of the silicon substrate. 
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Figure 4.7 Phase contrast microscopy images of A) 160 pm pore covered with 
fibroblasts, B) Focus on tissue culture plastic below 160 pm pore covered by 
fibroblasts and C) fibroblasts proliferating within restricted regions of cracked 
silicon nitride sample. 
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Figure 4.8 Bar chart showing percentage pore coverage with endothelial cells 
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Overall, it can be concluded that for endothelial cells on this substrate, the cells 
cannot cover pores of 80 µm or more diameter, are unaffected by pores of 30 
µm or less, and a linear relationship exists between cell coverage and pore size 
between 30 µm and 80 µm. 
4.3.3 3T3 Fibroblasts 
This cell type displays a more complex pattern of interaction with the pores 
than the endothelial cells. The results for 3T3 fibroblasts/pore interactions are 
shown in Figure 4.9/4.10. Here, the fibroblasts reached maximum cell 
coverage of the silicon substrate after 72 hours of culturing. As illustrated in 
Figure 4.10, beyond 72 hours, fibroblasts produced a blanket of cells that 
covered all pores. Up to and including the time point at 48 hours, the 
fibroblasts were unable to cover or partially cover the 80 µm and 90 µm pores. 
However, at 72 hours between 20 and 30% of these larger pores became 
covered. 
For the other pore sizes, the trend in fibroblast coverage is less apparent, in 
comparison with the endothelial cells, with fibroblast coverage found to be 
more variable. However, in general, fibroblasts were able to cover pores of 50 
µm and less. 
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Figure 4.10 Selection of phase contrast microscopy images of fibroblasts over a 
range of defined pore features (size increasing from left to right): A-C) 4 hours, 
D-F) 24 hours, G-I) 48 hours, J-L) 72 hours and M-O) 96 hours. 
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4.3.4 Comparison of endothelial cells and fibroblasts. 
Fibroblasts show a greater degree of mobility than endothelial cells. In Figure 
4.11, we can see time-lapse images with 10-minute intervals. Fibroblasts are 
able to move with flexibility over and around pores smaller than their own 
dimensions. In contrast, endothelial cells become attached to pores. Figure 
4.12, shows low cell density images of endothelial cells on a variety of pore 
templates. The endothelial cells appear to attach preferentially to the pore 
features. Furthermore, once attachment has taken place, movement is limited to 
advance and retraction around the pore features. 
Given the fact that the spread 3T3 fibroblasts (20 to 50 µm diameter) are 
significantly smaller then the endothelial cells (60 to 200 µm diameter) as 
illustrated in Figure 4.13, the ability of the smaller cell type to cover larger 
pores indicates a difference in the nature of interaction between the two cell 
types and pores. The mechanism by which fibroblasts can bridge the large 
pores is shown in Figure 4.14 where time-lapse images show confluent 3T3 
fibroblasts use neighbours as supports to cross pore features larger than the 
individual fibroblast dimensions. The idea of cells responding to the pores as a 
topographical discontinuity, are consistent with the findings of Curtis et al, 
where cells migrating along fibres would often attach laterally to cells already 
on the fibres or at bends to form "sail sheets" to cross to another topographical 
feature, where the depth was too great to overcome (Curtis and Clark 1990). 
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Figure 4.11 Time-lapse images of 3T3 fibroblasts over 35 pm pores: A-P) 10 
minute intervals. 
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Figure 4.12 Phase contrast microscopy images of endothelial cells attaching to 
a range of pore features. 
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Figure 4.13 Light microscope images (A) Endothelial cell covering a 50 µm 
pore. (B) 3T3 fibroblasts spreading around 60 pm pore. 
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Figure 4.14 Fibroblasts displaying co-operative behaviour at confluence to 
cross a 100µm pore over a 6-hour period. (A) 0 hours (B) 2.5 Hours (C) 5.0 
Hours (D) 6.0 hours. 
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The difference in the behaviour of the two cell types can be highlighted further 
through phalloidin staining, which confirms that the cells are responding to the 
pores as topographical discontinuities. Fluorescence microscopy images in 
Figure 4.15 show the two cell types around pores fixed with glutaraldehyde 
and stained with phalloidin. Light intensity cross-sections of the images reveal 
the lateral variations in the cytoskeletal distribution of each cell type. The 
cytoskeleton in the endothelial cells (Figure 4.15a) is limited by the boundary 
of the pore with concentrated regions of cross-linked actin around the edge of 
the topographical feature. In contrasts, the distribution of cytoskeleton in 
fibroblasts (Figure 4.15b) is unchanged by the pore boundary. 
Thus, the cell's mobility may be reflected by the amount and organisation of 
actin monomer present in the cell. With the endothelial cells, the actin 
monomer is polymerised at the pore edge. This results in concentrated regions 
of cross-linked actin around the edge of the topographical feature. The lack of 
further actin reflects its reduced ability to form new focal adhesion contacts, 
thus restricting movement of the cell to near or around the pore. Fibroblasts 
reorganize and redistribute the actin, which also form focal adhesion points at 
the edges of the pore. However, the fibroblasts form further focal contacts 
allowing them to orientate around the pore features and display greater 
mobility. As a result, the fibroblasts are able to cross the boundary of the pore 
and then use their neighbouring cells as support structures. 
124 
Chapter 4: Interactions of fibroblasts and endothelial cells with defined pore features. 
250 
, 200 y U+ 150 c 
cd 
100 
50 
0 
0 200 400 600 
Pixels 
Y 
t` 
i 
300 1 
200 
I00 
0 200 400 600 800 
Pixels 
Figure 4.15 Phalloidin stained images with analysis of cross-section to show 
cytoskeletal distribution of actin at the topographical features with (A) 
Endothelial cells over a 40-µm pore (B) 3T3 fibroblasts around a 50 µm pore. 
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4.3.5 Endothelial cells and 3T3 fibroblasts in co-culture 
3T3 fibroblasts in co-culture proliferated faster than the endothelial cells, 
reaching 70% of the cell population at confluence (Figure 4.16). In co-culture, 
neither the endothelial cells nor the fibroblasts covered 90 or 100 µm pores at 
any time point. Even at the 96 hours time point, when the rest of the surface 
was almost entirely covered, the 90 and 100 µm pores remained uncovered 
(Figure 4.17). 
As the pore diameter decreased from 50 µm to 5 pm, the number of pores 
covered by endothelial cells increased incrementally (Figure 4.16a). However, 
over this same pore range, the fibroblasts showed no discernable trend (Figure 
4.16b), which was consistent with fibroblast behaviour in single culture (Figure 
4.9). Fibroblasts in co-culture were in general able to cross pores 50 µm or 
smaller, once a critical cell density had been achieved. The single culture of 
fibroblasts showed that a 77% cell density was required before 80 to 90 µm 
pores would be covered (Figure 4.9). Therefore, with the fibroblasts only 
reaching a maximum of 70% of the total cell population in co-culture, there 
was not a sufficient cell density of fibroblasts to cross the 90 or 100 µm pores. 
This indicates that endothelial cells and fibroblasts will not co-operate in 
crossing the pore features. The addition of endothelial cells thus has an 
inhibitory effect by preventing fibroblast-to-fibroblast co-operation over pore 
features in the co-culture. 
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Figure 4.17 Selection of phase contrast microscopy images showing endothelial cells and 3T3 
fibroblasts in co-culture between day I and 3. 
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Whilst the larger pores were not covered by the endothelial cells in either 
single or co-culture, the endothelial cells will cover pores in the 50 to 5µm 
range. However, they appear to require a critical cell density within the co- 
culture, before a significant number of pores will become covered. This is in 
contrast to the endothelial cells in a single culture, where the probability that a 
pore was covered was increasing monotonously with total pore coverage. 
Furthermore, Figure 4.16 shows that endothelial cells in co-culture are not able 
to spread as effectively as endothelial cells in single culture. This will therefore 
decrease the size of pores that endothelial cells can cover through spreading, 
which is confirmed in the data presented in Figure 4.9. However, despite their 
smaller sizes, endothelial cells in co-culture, as illustrated in Figure 4.17 
exhibited behaviour similar to the single culture of endothelial cells, showing a 
preferential attachment to pores. 
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4.4 Conclusion 
The colonisation of biodegradable polymer scaffolds with cell populations has 
become established as the foundation for the engineering of a number of 
tissues, including cartilage, liver and bone. The formation of tissues in vivo 
necessitates the vascularization of such scaffolds if blood vessels are to reach 
the tissue. The infiltration of fibrous vascularized tissue results however in 
decreased porosity within the scaffold. Predicting the interactions between 
these cells and pores is important if scaffold characteristics are to be optimised. 
This study of cells over defined pore features has determined that cell 
behaviour is interlinked by three factors: 
1. Cell type 
2. Pore size 
3. Cell density 
It has also been shown that the cells respond to the pores as topographical 
discontinuities. The difference in behaviour of the two cell types is related to 
the cytoskeletal structure and actin monomer content. Fibroblast cells displayed 
greater mobility and a co-operative pattern of cell spreading in which pores 
with diameters greater than the cell dimensions were bridged by groups of cells 
using their neighbours as supports. In co-culture, this behaviour was inhibited 
to some extent by the endothelial cells by preventing fibroblast-to-fibroblast 
interactions. 
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Endothelial cells were unable to use neighbours as support structures and failed 
to bridge pores greater than the cell diameter in either single or co-culture. The 
endothelial cells appeared to attach preferentially to pores treating them as 
topographical discontinuities. Movement by these cells was then limited to 
around the pore feature. Furthermore, the large spread of endothelial cells is 
inhibited by fibroblasts in co-culture. 
In both cell types, cell density and pore size affected percentage pore coverage 
significantly. These results confirm that within a tissue engineering scaffold 
cells displaying fibroblast behaviour will tend to block pores even where the 
pore diameter is greater then the cell diameter, but that this behaviour can be 
modulated by the addition of non-fibroblastic cell types. 
These results show that the ability to control pore size is essential in controlling 
cell behaviour. This, therefore, provides the impetus for the manufacture of an 
injectable scaffold with highly porous morphology. 
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CHAPTER 5 
PHYSICO-CHEMICAL CHARACTERISATION OF AN IN 
SITU SELF-ASSEMBLING POROUS SCAFFOLD FOR 
TISSUE ENGINEERING. 
5.1 Introduction. 
A major goal of tissue engineering as described in Chapter 1, is the concept of 
growing cells within three-dimensional support scaffolds (Hutmacher 2000). 
Scaffold materials must satisfy a number of requirements. The solid phase must 
be biocompatible and promote cell adhesion and growth. Over time, as the cells 
produce their own ECM, the scaffold should degrade. Processing techniques 
must be able to produce irregular shapes to match those of the tissue to be 
replaced. High porosity is needed for cell seeding, ingrowth and successful 
vascularization of the scaffold. The material must also have sufficient 
mechanical strength for handling and in vivo loading. 
In broad terms, scaffolds are either a pre-formed water-insoluble matrix, with 
large interconnected pores, within which cells are seeded or a hydrogel that 
solidifies around the cell population (Burg et al. 2000; Kuo and Ma 2001). The 
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matrix scaffold is formed before cells are seeded and then it is either placed in 
a bioreactor for in vitro tissue formation or implanted into a patient for 
augmented in vivo tissue regeneration. Whilst, the three-dimensional cell 
culture environment within these porous scaffolds is favourable to tissue 
regeneration, the need to pre-form the scaffold before seeding and implantation 
is problematic. Cell seeding methods are inefficient due to poor transport of the 
cells through the matrix and cell damage. In terms of implantation, the scaffold 
must be shaped to fill a cavity within the body, requiring knowledge of the 
cavity dimensions and limiting the shape of cavity that can be filled. In 
addition, an invasive operation is required to deliver the large biomaterial. 
In contrast, a number of hydrogel materials have been designed that can be 
delivered directly into the body through a syringe. The gel forms within the 
body following a trigger signal. These include thermosensitive, biodegradable 
hydrogels consisting of blocks of poly (ethylene oxide) and poly (lactic acid) 
that display an upper critical solution temperature, forming liquids that are 
injectable at temperatures around 45°C and gels at body temperature (Jeong et 
al. 1997). Other systems include the use of acrylated PEG as a non-toxic 
crosslinking reagent to produce polymer networks with acrylated polylactic 
acid and acrylated copolymers based on lactic acid, which can be polymerised 
in situ (Han and Hubbell 1997) (Elisseeff et al. 1997). Water-insoluble 
interpolymeric complexes (IPC) containing poly (methacrylic acid) (PMA) 15 
kDa and polyethylene glycol (PEG), 20 kDa, in an organic solvent system that 
undergoes a sol-gel phase transformation when injected into a pH 7.4 buffer 
and the release of calcium from lipids to cross link alginates also demonstrate 
the wide variety of in situ transformations that are possible (Joshi et al. 1999) 
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(Westhaus and Messersmith 2001). A comprehensive review of in situ 
transforming biomaterials can be found in Chapter 1 
Such systems have the advantage that they can fill cavities of any shape 
without prior knowledge of the cavity dimensions. However, such hydrogels 
lack large interconnected porous networks, and hence the barrier of diffusion to 
signalling and nutrient molecules limits tissue formation. The lack of a porous 
structure also significantly reduces the scaffold's ability for vascularization. In 
addition, the mechanism of gelation may damage cells, hence prohibiting co- 
administration of cells. 
The aim of this work was to combine the advantages of injectable scaffolds 
with the necessary porosity of traditional water-insoluble scaffolds. Such a 
scaffold would require a trigger to transform once in situ, must be 
biodegradable and cell interactive. In Chapters 5 and 6, the development of a 
new porous scaffold is described that can be delivered by syringe into a tissue 
or cavity as a polymer and/or cell slurry. Immediately following delivery, the 
slurry would potentially self-assemble into a porous scaffold with cells 
distributed throughout. Self-assembly involves the cross-linking of polymer 
particles by the avidin-biotin mediated interaction. The self-assembly process 
could occur under physiological conditions and does not require cell harmful 
trigger signals such as UV irradiation. This is achieved by forming the polymer 
component of the scaffold, with microparticles manufactured from the 
biodegradable PLA-PEG-biotin synthesized in Chapter 3. The use of PLA-PEG 
microparticles in drug delivery and tissue engineering is established and thus 
common methods could be employed to signal to the cells within the scaffold 
134 
Chapter 5: Physico-Chemical Characterisation of a porous-self-assembling scaffold 
through growth factor delivery or integrin-mediated adhesion (Cannizzaro et 
al. 1998; Babensee et al. 2000). 
The potential for avidin to act as a crosslinking agent in aggregation has been 
previously described for a number of biotinylated moieties. For an example, in 
a study based on the aggregation kinetics in affinity purification of biotinylated 
liposomes, Lynch et al showed that the aggregation kinetics were primarily 
determined by the biotin density on the liposome surface, the stochiometric 
ratio of avidin molecules to liposomes and the liposome concentration (Lynch 
et al. 1996; Lynch et al. 1996). Although liposomes as drug delivery and tissue 
engineering devices suffer from inherent problems such as low encapsulation 
efficiencies, rapid leakage of water-soluble drugs in the -presence of blood 
components and poor storage stability (Soppimath et al. 2001), the parameters 
for aggregation used in their studies are likely to be significant for the 
aggregation of PLA-PEG-biotin microparticles. Further studies on the 
organization of inorganic nanoparticles using biotin-streptavidin connectors for 
the manufacture of ferritin-based arrays have been carried out by Li et al. It 
was found that there was a critical ratio of avidin to biotinylated ferritin 
molecules for supramolecular structures to be formed. Above and below these 
critical amounts of avidin, the turbidity decreased: thus indicating that the 
aggregate size was smaller (Li et al. 1999). Finally Chiruvolu et al showed 
higher order self-assembly of vesicles could be achieved by utilizing the biotin- 
avidin interaction in a two stage self-assembly process. In the primary self- 
assembly process, lipid molecules self-assembled into spherical vesicles as a 
result of non-specific intermolecular forces. These spherical vesicles then self- 
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assembled into the higher order structures using the biotin-streptavidin 
mediated interaction (Chiruvolu et al. 1994) 
In Chapter 5, the manufacture of the microparticles that form the foundation of 
the self-assembling scaffolds is described. Evidence that these particles will 
undergo the binding process is assessed by SPR. The aggregation process is 
then probed and optimized using a variety of quantitative and qualitative 
techniques and finally the viscoelastic properties of the scaffold are evaluated. 
For the tailoring of mechanical properties, a gel-forming component, biotin- 
PEG-biotin is introduced and its impact on the scaffold assessed. 
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5.2 Methods and materials 
5.2.1 Preparation of PLA-PEG-biotin 
PLA-PEG-biotin was synthesised as described in Chapter 3. 
5.2.2 Preparation of Biotin-PEG-Biotin 
cc-co-bis(amine) PEG (lg) was dissolved into acetonitrile (2m1), methylene 
chloride (iml), Et3N (8Oµ1) and NHS-Biotin (0.50g). The reactants were stirred 
overnight under argon and then worked-up by diethyl ether (40m1) to 
precipitate the polymer. The isolated material was then dissolved in hot 
isopropanol (70°C) to give an opaque-cloudy solution. On cooling, the product 
was filtered and lyophilised. 
5.2.3 Preparation of nano/microparticles 
500mg of PLA-PEG-biotin was dissolved in 20m1 of dichloromethane (DCM) 
to produce a 25mg/ml solution. PVA (250000 Mw) [88% hydrolysed] was 
dissolved into ELGA water (0.25g into 250 ml) to make a 0.1% w/v solution. 
The PLA-PEG-biotin solution was then added to a homogenised PVA solution 
using a 5m1 Gilson pipette. The mixture was homogenised for a further 10 
minutes at 1500 rpm and then left stirring overnight for DCM to evaporate and 
microparticles to form. Nanoparticles were prepared as above with a 9% PVA 
solution and homogenisation at 5000 rpm and a 5mg/ml solution of PLA-PEG- 
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biotin. Further nano/microparticles were manufactured using 0.1,1 and 9% 
PVA at stirring rates of 1500,3500 and 5000 rpm. 
5.2.4 Preparation of scaffold composites 
Avidin saturated microparticles were prepared by placing PLA-PEG-biotin 
particles in an excess of avidin, centrifuging and washing. The excess amount 
of avidin was determined on the basis of aggregation studies. This quantity 
increased with decreasing size of particles. A typical batch was prepared by 
introducing 10 mg microparticles into a stirring 10 ml aqueous solution of 20 
mg avidin. 
Biotin-PEG-biotin was introduced to scaffolds by dissolving the biotin-PEG- 
biotin in water and introducing this solution to the avidin bound microparticles. 
Where percentage proportions of the scaffold are quoted, these are weight-by- 
weight proportions e. g. a 10 mg (30% biotin-PEG-biotin/50% avidin saturated 
microparticle) scaffold will be made up of 3mgs biotin-PEG-biotin dissolved in 
2 mg water which has then been introduced to 6 mgs avidin saturated 
microparticles. For the purposes of measuring the effects of avidin on 
aggregation and rheometry of microparticles where the quantities of material 
tested varied, the ratio of the microparticles to the avidin on a weight by weight 
basis are quoted. In the aggregation studies, the avidin activity was not assayed 
and this data must therefore be considered qualitative. However, data on the 
molar binding affinity of the biotin in PLA-PEG-biotin can be found in chapter 
3. Avidin has an activity of 10-15 units per mg, where 1 unit will bind I µg of 
d-biotin 
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5.2.5 Surface plasmon resonance (SPR) 
The SPR equipment (Ortho Clinical Diagnostics, Chalfont, St-Giles, UK) 
employs a Kretschmann configuration with a monochromatic laser source of 
780nm wavelength and silver coated glass slides biotinylated by incubating in 
a 0.1 mg/ml solution of N-([6-biotinamido-]hexyl-)3'-[2'pyridylthio] 
propionamide in TFE. PLA-PEG-Biotin nanoparticles (250nm) were saturated 
in excess avidin and washed using centrifugation. The avidin-saturated 
nanoparticles (1.5 x 10"' M), were then prepared in 10 mM sodium phosphate 
buffer (pH 7.4). For the purposes of a stable baseline reading, a sodium 
phosphate buffer wash (10mM, pH 7.4) was first passed over the biotin-HPDP 
functionalised surface for 100 s. Avidin functionalised surfaces were then 
obtained by flowing avidin solution (1.5 x 10"7 M) over the biotinylated slides. 
To remove any excess avidin, sodium phosphate buffer (10mM, pH 7.4) was 
then washed over the surface. Then biotin-PEG(3350)-biotin (1 x 10-6 M) was 
flowed across the sample surface, followed by a buffer wash. Avidin-saturated 
nanoparticles (1.5 x 10"' M) were then flowed over the surface followed by a 
buffer wash. As a control experiment, unsaturated PLA-PEG-Biotin 
nanoparticles (1.5 x 10"' M, 250nm), were injected in place of the avidin- 
saturated nanoparticles following the avidin and biotin-PEG-biotin injections. 
A further control involved injecting avidin alone over the experimental time 
period. The flow rate was 0.24 mL/min with results taken from at least 8 
repeats. The change in the SPR angle was monitored over time, in units of 
millidegrees angles (mDA) where 1 mDA = 0.0010. 
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5.2.6 Microscopy 
Phase contrast images were taken on an optical microscope (Leica DMIRB) 
attached to a Leica Q500 IW using a colour video camera (JVC TK-C1380). 
This was equipped with a fluorescence filter to enable fluorescein imaging. 
5.2.7 Transmission Electron Microscopy 
Visual evaluation of the nanoparticles before and after the addition of avidin 
was performed using transmission electron microscopy (TEM). 20 µl of sample 
(5 µg/ml) in PBS were placed onto copper grids for 5 minutes. Excess liquid 
was blotted with filter paper, and the process was repeated. Following air- 
drying, grids were then negatively stained by floating on a drop of 
phosphotungstic acid solution (3% w/v) (adjusted to pH 4.74 with KOH) for 20 
minutes, after which they were washed once in 50% ethanol and then twice in 
distilled water, prior to being air-dried again. Grids were analysed on Jeol Jem 
1010 TEM (Jeol (UK) Ltd, Welwyn Garden City, UK), operating at a voltage 
of 80 kV. 
5.2.8 Cryo Scanning Electron Microscopy (Cryo-SEM) 
CryoSEM was chosen over traditional SEM so that aggregated microparticles 
detected were as a result of the receptor-mediated binding interaction and not 
dehydration. Samples were prepared by mixing samples of microparticles with 
the optimum amounts of avidin for aggregation in distilled water. These 
samples were then placed onto the sample holder coated in colloidal graphite 
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and rapidly frozen in liquid nitrogen (-210°C), etched under vacuum (-80°) and 
gold-coated. Images were obtained at 25 KeV on a Philips 505 scanning 
electron microscope equipped with a Hexland CT 1000 cryostation, maintaining 
the specimen at 
-180°C throughout. 
5.2.9 Nanoparticle Size analysis: 
Nanoparticle size was determined using photon correlation spectroscopy (PCS) 
(Malvern S4700 PCS system, Malvern Instruments Ltd, Malvern, UK). The 
analysis was performed at a scattering angle of 90°C and at a temperature of 
25°C using 1 ml samples diluted with filtered water (0.2 µm filter, Minisart®, 
Germany). For each sample, the mean diameter ± standard deviations of six 
determinations were calculated applying multimodal analysis. Values shown 
are the mean diameter for two replicate samples. The final concentrations of 
nanoparticles were prepared by suspending 50 pg of the nanoparticles in 1,2 
and 10m1 of water. Varying avidin quantities were then introduced to stirring 
or agitated suspensions of the nanoparticles. Random 100 t1 samples were then 
taken and diluted to 1 ml with filtered water. 
5.2.10 Spectrophotometer sedimentation studies 
10 mg samples of PLA-PEG-biotin microparticles (--10 micron) were prepared 
in 1 ml aliquots of water with varying concentrations of avidin (0 to 10 mg). 
Kinetic studies over a period of 60 minutes were carried out using the Iml 
samples on the Beckman DU640 spectrophotometer with an analytical 
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wavelength of 700 nm at 37°C with a read average time of 5 seconds. 
Gradients were calculated using linear lines of best fit. 
5.2.11 Particle size measurement 
The evolution of size of the aggregates was monitored using a particle size 
analyser (Coulter LS230). The instrument applies the principle of forward light 
scattering by particles to measure the particle size distributions. The size 
distributions were estimated by fitting the intensity of the scattered light (? = 
750 nm) as a function of the scattering angle (0 = 0.017-34°C). They were then 
compared by the instrument to the scattering patterns of spherical particles of 
the same size calculated by the Mie model of light scattering by particles. 
Significant differences from this model occur, only if particles are very non- 
spherical. The critical concentration of samples required for each measurement 
varied and therefore the ratio of avidin to microparticles within each sample is 
quoted on a weight-by-weight basis. 
5.2.12 Oscillatory shear measurements 
Oscillatory shear measurements was performed using a controlled stress 
rheometer (CS 10, Bohlin) fitted with a cone and plate (4° geometry) and used a 
frequency range of 0.1 
-5 rad/s at 37°C. The linear viscosity region (where 
stress is proportional to strain) was determined by stress sweep measurements 
in order to carry out measurements at stresses that did not damage the scaffold 
structure. Tan S= G"/G' where G' and G" are the storage and loss modulus 
and S is the loss angle. A gel structure normally results in G' being greater than 
G" whilst a non-gel structure will result in G">G'. Measurements dependent 
on shear rate were made over the 0.1 
- 
100 s'1 region. 
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5.3 Results and discussion 
The novel scaffold described in this chapter possesses the advantages of both 
porous matrices and in situ forming gels, generating porous scaffolds that self- 
assemble at the site of injection. Figure 5.1 is a schematic representation of the 
process of scaffold self-assembly. We start with particles of poly (lactic acid)- 
poly (ethylene glycol)-biotin (PLA-PEG-biotin) (Cannizzaro et al. 1998) that 
are formed using a single emulsion method. The particles are then crosslinked 
together by co-injection with the cross-linking protein avidin, to form an 
interconnected macroporous structure. 
In the development of the scaffold, the first step was to manufacture the nano 
and microparticles from PLA-PEG-biotin, which was synthesized and 
characterised in Chapter 3. The use of microparticles has been despribed in 
many tissue-engineering applications. Examples include microparticles that 
have been used for a variety of tissue regenerative purposes from tissue bulking 
in urinary incontinence, regeneration of dermis-like tissues through the release 
of basic fibroblast growth factor to delivering nerve growth factor to enhance 
axonal regeneration following injury to the central nervous system (CNS)(Cao 
and Shoichet 1999; Kawai et al. 2000). The potential of combining the avidin- 
biotin system with nanoparticle technology has also been recently 
demonstrated in carrier systems with biotinylated drug derivatives for antisense 
therapy for HIV infections (Coester et al. 2000). 
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" 
Binding 
-- Biotin group 
Biotinylated PLA-PEG microparticle 
Self-assembly 
of scaffold 
Figure 5.1 Schematic of the process of scaffold self- assembly. 
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5.3.1 Manufacturing of microparticles 
As described in Chapter 1, PLA-PEG copolymers display hydrophobic- 
hydrophilic type characteristics that result in a PEG enriched surface when 
manufactured into microparticles (Hrkach et al. 1997). Because biotin is 
tethered onto the end of the PEG chain in the PLA-PEG-biotin copolymer, this 
also results in a biotin rich surface. 
Whilst previous biotinylated particle systems such as latex-biotin particles, 
were not able to link because of steric hindrance effects caused by the two 
approaching particles; microparticles manufactured from PLA-PEG-biotin 
polymer overcome this through the use of PEG as a spacer group for the biotin 
unit. The PEG also increases biotin-avidin binding efficiencies (Chem et al. 
1996). 
A commonly used emulsion stabilizer in the solvent evaporation method for 
PLA-PEG microparticle preparation is partially hydrolyzed PVA, which is a 
copolymer of poly (vinyl acetate) and poly (vinyl alcohol). The choice of an 
88% hydrolysed PVA was made because a study by Murakami et al found this 
to be the optimum degree of hydrolyzation of PVA for the manufacture of 
nano/microparticles (Murakami et al. 1997). 
The binding of PVA to the microparticles may be through the interpenetration 
of PVA and PLA-PEG molecules. The irreversible binding of PVA on the 
microparticle surface is likely to happen when the organic solvent is removed 
from the interface in which interpenetration of PVA and PLA-PEG molecules 
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occur. The impact of a mixed PVA interfacial zone with the PEG enriched 
surface will be in the masking of biotin binding sites at the PEG end groups. 
However, previous work by SPR has shown that significant avidin 
immobilisation still occurs after PVA adsorption with masking up to only 30%, 
suggesting that there are sufficient biotin binding sites retained on the surface 
of the microparticle (Black et al. 1999). 
The ability to control particle size is demonstrated in Table 5.1, where particle 
size is governed by the stirring rate, with the minimum sizes of the 
microparticles determined by the PVA concentrations of the continuous phase. 
This is important not only in dictating the porosity of our scaffolds through the 
interstitial spaces generated through aggregation of the microparticles, but also 
because it has been found that there is a linear relationship between the 
degradation rate and particle size, with larger particles degrading faster. In 
smaller particles, degradation products formed within the particle can diffuse 
easily to the surface, while in larger particles degradation products have a 
longer path to the surface of the particle during which autocatalytic degradation 
of the remaining polymer can occur (Dunne et al. 2000). 
It is also possible to control the porosity of the individual microparticles to 
have a secondary form of control over the scaffold's overall porous structure. 
This is advantageous because particles with varying porosities can alter release 
rates of growth factors or allow cell infiltration. This could be achieved by 
using higher temperatures during the manufacture, which results in rapid 
solvent evaporation. 
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PVA conc. Stirring rate Average Size Polydispersity 
(%, w/w) (rev. /min) (micron) 
0.1 1500 9.9 0.29 
3500 5.2 0.31 
5000 2.1 0.33 
1 1500 3.2 0.26 
3500 1.9 0.35 
5000 1.7 0.39 
9 1500 1.4 0.34 
3500 0.6 0.39 
5000 0.25 0.55 
Table 5.1 Parameters controlling microparticles size. 
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This causes local explosion inside the droplets and leads to the formation of 
porous structures throughout the microspheres (Jain 2000; Yang et al. 2000). 
This is illustrated in Figure 5.2 by a batch of PLA-PEG-biotin microparticles 
that were manufactured at the higher temperature of 37°C. 
In the case of tissues where increased load bearing was necessary, an additional 
gel-forming component biotin-PEG-biotin could be added to a mixture of 
avidin-saturated particles to enhance the mechanical properties of the scaffold. 
The self-assembly was achieved in these examples by the biotin-avidin 
mediated interaction between the biotin unit attached to the PEG and the avidin 
on the surface of the nanoparticles. The next stage was to therefore assess the 
binding processes involved in the scaffold formation. 
5.3.2 Surface Plasmon Resonance (SPR) binding studies 
The mechanisms of self-assembly were explored by SPR analysis. The specific 
receptor-mediated nature of the crosslinking is demonstrated in the SPR data in 
Figure 5.3. The silver coated SPR slides were modified with a biotin- 
presenting monolayer by exposure to N-([6-biotinamido-]hexyl-)3'- 
[2'pyridylthio]propionamide. Successive layers of avidin, biotin-PEG-biotin, 
avidin and PLA-PEG-biotin nanoparticles were then built upon this surface. 
The addition of each layer, via specific avidin-biotin interactions, was detected 
by an increase in the SPR angle. 
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Figure 5.2 SEM image of microparticles manufactured at A) 24°C and E3) 37°C 
showing that the increased temperature for solvent evaporation results in highly 
porous microparticles. 
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An increase of 125 mDA corresponded to a monolayer of protein coverage 
based on previous work (Green et al. 1997). However, the shift was smaller 
than that of the binding of avidin with films of PLA-PEG-biotin (181.58 mDA) 
in Chapter 3. This provides further confirmation that the hydrophilic nature of 
the PEG block allows it to act as an effective spacer molecule for the biotin, in 
comparison to the two-dimensional biotin-HPDP adsorbed onto the silver slide. 
A further small shift of 25-35 mDA was seen as a result of the biotin-PEG- 
biotin injection. Finally, a large shift of 250-260 mDA was detected on 
injection of the avidin-saturated nanoparticles. 
Control experiments with just avidin injected over the biotin surface produced 
a continuous plateau without the injection of biotin-PEG-biotin or the 
nanoparticles. Avidin saturated nanoparticle binding to the biotin-PEG-biotin 
was found to plateau within 150 secs following the introduction of the 
nanoparticle solution suggesting that the crosslinking process could occur 
rapidly. A further control was performed to confirm that specific avidin-biotin 
binding generated the large 6SPR shift. In this control, nanoparticles without 
avidin were injected over the biotin-PEG-biotin layer hence preventing any 
bridging interactions between the two components through the avidin 
interaction. A OSPR increase of only 10-20 +/- 2/3 mDA was recorded 
confirming that the large OSPR increase seen for the avidin-saturated 
nanoparticles was a specific receptor-mediated interaction. 
This data shows that a) avidin attaches to the surface of the particles b) biotin- 
PEG-biotin binds efficiently to avidin, c) particles coated in avidin bind to 
biotin-PEG-biotin and d) the biotin-avidin mediated interaction is a specific 
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instantaneous binding process. Having shown that each component of the 
scaffold had maintained their binding properties after manufacture, it was then 
necessary to optimise the aggregation process. 
5.3.3 Aggregation studies on nanoparticles 
The initial plan for scaffold formation was to be dependent on the linking of 
particles through the avidin-biotin mediated interaction. Aggregation studies 
were carried out to determine optimum particle: avidin ratios. The ability to 
control the porosity in the self-assembling scaffolds is achieved through control 
of particle size, which then determines the size of the inters* al spaces 
generated when the particles aggregate together. Thus to prove that porosity 
could be controllable within the scaffold, it was necessary to show that 
aggregation could be achieved with both nanoparticles and microparticles. 
Starting with nanoparticles, particle size analysis was conducted using photon 
correlation spectroscopy (PCS) and transmission electron microscopy (TEM). 
Figure 5.4 shows the aggregation data of 50 µg samples of 250 nm PLA-PEG- 
biotin particles. Up to 0.1mg of avidin had negligible effects on the aggregation 
of the nanoparticles. It is possible that small aggregates may have formed but 
were not sufficiently present to be selected during random sampling of the 
suspension. Increasing up to 0.4 mg of avidin showed a consistent increase in 
the size of aggregates reaching optimum aggregation levels at 0.35 mg. Beyond 
this quantity of avidin, a decrease in aggregate size was detected. 
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Figure 5.4. Photon correlation spectroscopy (PCS) data on the aggregation of 
different dilutions of PLA-PEG-biotin nanoparticles with the addition of avidin 
to determine nanoparticle concentration and avidin to nanoparticle ratio effects 
on aggregation. 
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Increasing avidin further resulted in further falls in the overall aggregate size 
until a plateau was observed after 0.9mg of avidin. 
Assessment was then made on the influence of the concentration of the 
suspensions of nanoparticles. The optimum aggregate size increased as the 
concentration of the nanoparticle suspension increased. At 5 µg/ml, optimum 
aggregate sizes around the 1-micron size were observed. This increased to 
optimum aggregate sizes of approximately 2.5 microns for 50 pg/ml 
nanoparticle suspensions. Beyond this point, the aggregates were too large for 
the sensitivity of the PCS equipment. However it could be seen that aggregate 
sizes formed from nanoparticles was dependent on the concentration of the 
nanoparticle suspensions. Increasing concentrations resulted in larger 
aggregates, as more nanoparticles were in contact when avidin was added. 
Further evidence of this was seen when an optimum amount of avidin was 
added to a concentrated suspension of nanoparticles and assessed by TEM. 
Figure 5.5 shows the nanoparticles before and after addition of avidin clearly 
illustrating the aggregating effect of the avidin-biotin binding process. Having 
shown that it was possible to optimise nanoparticle aggregation, it was 
necessary to show that aggregation of microparticles could also be optimised. 
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Figure 5.5 TEM images of A) PLA-PEG-biotin nanoparticles without avidin 
and B) after addition of avidin. 
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5.3.4 Aggregation studies on microparticles 
An initial assessment on whether PLA-PEG-biotin microparticles would 
crosslink together upon addition of avidin was made by mixing 10-micron 
particles with rhodamine-conjugated avidin (Av-Rh) (Figure 5.6). Microscopy 
images of large aggregates up to 1 mm in size were observed. 
Because the microparticles were above the sensitivity range of the PCS 
equipment, aggregation studies were carried out using two alternative methods; 
sedimentation and particle size analysis (Coulter LS230). These complimentary 
techniques were chosen because individually each method has some 
drawbacks. Particle size analysis by sedimentation provides a simple effective 
non-destructive method of measuring aggregate sizes, where the apparent 
volume fraction is a function of the light obscured in the sample, but the 
method lacks the accuracy of the particle size analyser (Coulter LS230). The 
size distribution measured by the particle size analyser is an equivalent volume 
based size distribution for particles, as calculated by the Mie theory from the 
scattering patterns of aggregates. However, the software assumes all particles 
are spherical, but when particles aggregate together, many different shapes can 
be formed. These do not necessarily correspond to the shape of the primary 
particles. Measurements also take place under agitated stirring conditions. 
Clearly, restructuring of this nature could have a substantial effect on the size 
of aggregates, as the undisturbed aggregate with more tenuous structure 
occupies a larger space than that of the restructured aggregate. 
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Figure 5.6 Microscopy images of PLA-PEG-biotin microparticles A) showing 
small unaggregated microparticles before addition of rhodamine conjugated 
avidin and B) after addition of the fluorescently labelled crosslinking agent 
showing large aggregates. 
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However, a comparison of the particle size analysis by sedimentation with that 
by the Coulter LS 230 does provide satisfactory correlation on the effects of 
the avidin on the aggregation of microparticles. The results presented have also 
been produced from the same batch of avidin, as a key difficulty in these 
aggregation studies was batch-to-batch variations in the activity of the avidin. 
In sedimentation studies, the rate of decrease (RD) in absorbance increased as 
the size of the aggregates increased (larger aggregates settle out faster allowing 
more light to get through quicker). Sedimentation studies were carried out 
using 10 mg/ml microparticles. In Figure 5.7 it can be seen that up to 0.1 mg of 
avidin, the RD increased sharply from 0.004 to 0.02. Further increases in the 
amount of avidin resulted in more gentle increase in RD reaching an optimum 
0.0285 at 2mg avidin. Further amounts of avidin then resulted in the RD 
decreasing again, falling to 0.01 for 10mg of avidin. 
Similarly, the Coulter LS230 data shown in Figure 5.8 showed a single 
distribution of 10-micron particles without avidin. Upon addition of avidin, the 
distribution became multimodal showing increasing aggregate sizes with 
increasing amounts of avidin up to 2mg. Saturation of the microparticles with 
avidin also resulted in a multimodal distribution but with aggregate sizes 
significantly smaller indicating that an excess of avidin prevents optimal 
aggregation from occurring. 
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Figure 5.7 Aggregation studies using sedimentation to show rate of decrease in 
absorbance for 10 mg/ml PLA-PEG-biotin particles (40 µm) with varying 
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This data reveals a consistent relationship between particle surface area, avidin 
concentration, and aggregation. At low avidin concentrations there are 
insufficient bridging points due to the scarcity of the protein. At high avidin, 
concentrations there are insufficient free biotin molecules on the surfaces of the 
particles to achieve cross-linking. This is illustrated in Figure 5.9 by CryoSEM 
images of PLA-PEG-biotin microparticles placed in an excess of avidin, 
resulting in limited aggregation. At intermediate avidin concentrations, the 
probability of a surface-bound avidin molecule encountering a free biotin on a 
neighbouring particle is maximized. This results in the formation of large 
closely packed microparticle aggregates creating a large three-dimensional 
macroporous structure, which forms an interconnected porous system (Figure 
5.10). The precise concentrations of avidin that generate cross-linking are 
dependent on the surface area of the polymer populations and therefore, 
nanoparticles require more avidin per unit mass than microparticles. 
5.3.5 Rheological determination of mechanical properties 
Scaffolds for tissue regeneration purposes require defined mechanical 
properties. A proposed advantage of the scaffold presented is the ability to 
tailor the viscoelastic properties of the scaffold to that of the area in which 
tissue regeneration is required. 
Rheological measurements on microparticle aggregates whilst demonstrating 
the crosslinking properties of avidin highlighted the lack of mechanical 
strength of these scaffolds. This was a problem both in terms of rheological 
characterisation through seepage of the composites and reaching targeted 
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mechanical requirements of traditional scaffolds described in Chapter 1. In 
order to strengthen the scaffold, biotin-PEG-biotin was introduced. The 
binding affinity of biotin-PEG-biotin was first probed in SPR analysis but the 
complexities of introducing avidin to a biotin-PEG-biotin solution meant that 
avidin could not be used as the crosslinking agent. The most obvious hurdle 
was that avidin was binding to the biotin-PEG-biotin and therefore not 
crosslinking the microparticles. This was overcome by preparing the 
microparticles with avidin first as described previously. Solutions of biotin- 
PEG-biotin were then introduced to the avidin-bound microparticles as the 
crosslinking agent. Biotin-PEG-biotin was first used at a constant proportion to 
investigate the impact of the percentage of microparticles by weight in these 
scaffold composites and the impact of the ratio of microparticles to avidin. 
Figure 5.11 show that the addition of avidin results in a transition in the 
mechanical properties of the scaffold. The avidin appears to impact on the 
scaffold in two ways. 
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Figure 5.9 CryoSEM images of 10-micron PLA-PEG-hiotin microparticIes 
saturated in avidin showing limited aggregation. 
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Figure 5.10 CryoSEM images of A) 10 micron PLA-PEG-biotin microparticles 
without avidin and B) after addition of avidin showing the interconnected 
macroporous structure of the large aggregates formed. 
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Figure 5.11 Mechanical spectra (elastic modulus G'/ viscous modulus G" and 
Tan S versus frequency of applied strain) with "I the linear viscoelastic region. 
A) Comparison of viscoelastic properties of scaffold (50% PLA-PEG-biotin 
microparticles/25%PEG-biotin) at 37°C with and without avidin treatment and 
B) plot of Tan S over a 0.1 
-5 Hz frequency range with 50% PLA-PEG-biotin 
microparticles/25% Biotin-PEG-Biotin without dvidin and with saturated and 
washed microparticles with avidin. The 1=2 ratio denotes saturation of 
microparticles with twice the amount of avidirl on a weight-by-weight basis 
prior to washing and centrifugation. 
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The first is that the overall viscosity increases from between 200 and 500 Pa 
for avidin free scaffolds to between 500 and 1200 Pa for scaffolds with the 
crosslinking protein. Furthermore the frequency dependent studies illustrate 
that the scaffolds undergo gelation upon addition of avidin. Scaffolds display 
viscoelastic liquid properties without any of the avidin crosslinking agent 
(G">G'). At optimum avidin concentrations, the scaffold behaves as a 
viscoelastic solid: the storage modulus is greater than the loss modulus over the 
whole frequency range. Avidin therefore acts as a crosslinking agent creating a 
multidimensional network (gel). Further clarification of this is seen through a 
change in the loss angle (Tan S) value (i. e. the ratio of G" to G'). This changes 
from values above 1 (non-gel) over the frequency range for samples without 
avidin to below 1 (gel) for samples with the crosslinking agent. 
A series of studies on microparticle: avidin ratios illustrated in Figure 5.12, 
show that a critical quantity of avidin is required for gelation to occur. For 
scaffolds without avidin, values at approximately 4 Pa were measured. This 
increased proportionally with addition of avidin. At optimal avidin 
concentrations, values between 12 and 19 Pa (increasing with frequency) were 
measured. Increasing amounts of avidin also lead to greater proportions of the 
storage modulus component of the scaffold. For example, a scaffold without 
avidin gave Tan 8 values above 1.5 indicating that the scaffold was not a gel. 
Low microparticle to avidin ratios (20: 1), whilst lowering the Tan 8 value to 
between 1.1 and 1.2, were not sufficient to form the gel structure. 
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Figure 5.12 Mechanical spectra (elastic modulus G'/ viscous modulus G" and 
Tan 6 versus frequency of applied strain) within the linear viscoelastic region. 
A) Plot of G' and G" values over a 0.1 
- 
5Hz frequency range with varying 
PLA-PEG-biotin microparticles to avidin compositions (10% microparticles in 
25% Biotin-PEG-biotin) and B) plot of Tan 6 over a 0.1- 5Hz frequency range 
with varying PLA-PEG-biotin microparticle to avidin compositions (10% 
microparticles in 25% Biotin-PEG-biotin) 
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A 10: 1 ratio of microparticles to avidin was sufficient to form a weak gel, but 
the gel structure strengthened with increasing amounts of avidin. Thus, the 
ratio of the avidin to microparticles is directly related to the gel properties of 
the scaffold. This corresponds with the aggregation data by sedimentation and 
particle size analysis. 
Comparing the data in Figure 5.13 with scaffolds using 50% microparticles to 
that of 10% microparticles in Figure 5.14 illustrates that increasing the 
percentage of microparticles in the scaffold will strengthen the viscoelastic 
properties of the scaffold. Scaffolds containing 10% microparticles without 
avidin displayed viscosities of 4 Pa. This was compared to scaffolds with 50% 
microparticles (without avidin), which had displayed values at approximately 
400 Pa. Thus increasing the percentage of microparticles five-fold increased 
the viscosity by a 100-fold. Furthermore, increasing the microparticle 
concentration can increase the effect of avidin. For example, scaffolds 
containing 10% microparticles with avidin displayed values between 12 and 18 
Pa. This was compared to scaffolds containing 50% microparticles with avidin, 
which displayed viscosities at approximately 1200 Pa. 
5.3.5.1. The impact of biotin-PEG-biotin on the mechanical properties 
Shear rate dependent studies have also highlighted the influence of the 
proportion of biotin-PEG-biotin on the viscoelastic properties of the scaffold. 
A comparison of microparticles before and after the addition of avidin was 
performed over a 0.01 to 100 s'1 range (Figure 5.13). The mechanical spectra 
show that avidin increases the overall viscosity of the samples, providing 
further evidence of the crosslinking process. 
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Figure 5.13 Shear rate dependent studies over a 0.1 
- 
100 s'1 range comparing 
scaffolds before and after crosslinking with avidin using A) 50% microparticles 
and B) 50% microparticles/ 25% biotin-PEG-biotin. The 1: 2 ratio denotes 
saturation of microparticles with twice the amount of avidin on a weight-by- 
weight basis prior to washing and centrifugation. 
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The addition of biotin-PEG-biotin resulted in a substantial increase in viscosity 
from between 2.2 
- 
4.1 Pa. s at 5 s"1 for scaffolds without biotin-PEG-biotin to 
267-561 Pa. s at 5 s'1 for scaffolds with the bifunctional PEG. The biotin-PEG- 
biotin not only increases the overall viscosity of the scaffold but also increases 
the gel-forming properties of the avidin crosslinking agent. 
The data (Figure 5.13) further shows that the scaffold displays shear thinning 
behaviour as characterised by the gradual increase in apparent viscosity with 
increasing rate of shear. The restructuring of aggregates due to hydrodynamic 
forces experienced by aggregates at higher shear rates leads to a steady state in 
aggregate size distribution, which is expected as higher shear rates (and hence 
greater shear stresses) would promote more collisions and thus a faster break 
up rate. However, in Figure 5.14, it can be seen that the point at which 
restructuring takes place, occurs at increasingly higher shear rates as the 
amount of avidin increases. For an example, in a scaffold without avidin, 
restructuring occurred between 0.1 and 1 s"1. This point at which this 
restructuring occurred increased to above 10 s-1 for scaffolds with avidin. This 
data indicates that avidin plays an organisational role within the scaffold, 
which must be broken before flow can occur and is consistent with both the 
oscillatory measurements and the aggregation studies. 
Thus rheological data has shown that controlling the concentrations of the 
various components within the scaffold can alter mechanical viscoelastic 
properties. For an example, increasing the proportions of microparticles, avidity 
or biotin-PEG-biotin can increase the overall viscosity of the scaffold and thus 
its load-bearing properties. 
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5.4 Conclusion 
A fundamental physico-chemical study on the potential for a porous in situ 
solidifying scaffold has been presented. The main component, biodegradable 
PLA-PEG microparticles are sterically stabilised in a physiological liquid prior 
to scaffold formation. These microparticles have been demonstrated by SPR to 
have sufficient biotin units on the surface to undergo binding with avidin 
rapidly and specifically. 
At precise concentrations of avidin, a cross-linking of the microparticles occurs 
and a scaffold forms. Above and below these concentrations, optimal 
aggregation is prevented through insufficient binding sites or saturation of the 
binding sites. 
Tailoring the individual components of the scaffold may be used to optimise 
the mechanical properties. Where increased load bearing properties are 
necessary, bi-functional PEG can be added to increase the gel-forming 
component in the scaffold. 
The procedure has also been demonstrated with nanoparticles (--250 nm 
diameter) and microparticles (40 µm diameter) of PLA-PEG-biotin to 
illustrate the possibility of controllable properties such as porosity and 
degradation rates through variation in particle size. 
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Having shown that PLA-PEG-biotin microparticles will self-assemble to form 
scaffolds with gel-like structural properties, the next stage was to identify 
potential applications for the scaffold. In Chapter 6, the use of the self- 
assembling process in cell delivery and in forming defined three-dimensional 
scaffolds is investigated. 
173 
Chapter 6: Three-dimensional porous polymer and cell composites that self-assemble in situ 
CHAPTER 6 
THREE-DIMENSIONAL POROUS POLYMER AND CELL 
COMPOSITES THAT SELF ASSEMBLE IN SITU 
6.1 Introduction. 
Injectable gels have found many applications as cell delivery devices in tissue 
engineering. For example, Cao et al. have demonstrated the use of 
PEO/PPO/PEO copolymers mixed with isolated chondrocytes, to initiate 
formation of a layer of cartilage on host bone. The painted chondrocytcs- 
polymer solution formed a semi-solid sticky gel within minutes. This newly 
formed cartilage then infiltrated the underlying osseus substrate to form a 
bone-cartilage interface. Such cell/polymer suspensions have been used for the 
formation of cartilage on the dorsum of mice using injectable systems (Vacanti 
et al. 1991; Cao et al. 1997; Temenoff and Mikos 2000). The delivery of 
chondrocytes within injectable gels has also been described for a number of 
other materials. These include alginate and PEO gels that have been used to 
produce injectable three-dimensional templates for cartilage formation, 
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although alginates are immunogenic and have poor resorbability and PEO 
based gels are not biodegradable (Atala et al. 1993). 
These hydrogels however do not have large interconnected porous networks 
and, hence, the barrier of diffusion to signaling and nutrient molecules limits 
tissue formation. In addition, the mechanism of gelation as described in 
Chapter 5 may damage cells. 
Furthermore the formation of defined three-dimensional scaffolds has to date 
been restricted to materials that are not capable of undergoing injection. Such 
scaffolds are generally processed using toxic solvents and require pre- 
fabrication prior to cell transplantation. This results in inefficient cell seeding, 
as isolated cells need to be transported throughout the scaffold. 
In Chapter 5, a novel self-assembling scaffold was described that combined the 
benefits of water-insoluble porous scaffolds and injectable gels. The 
mechanism of self-assembly was based on the avidin-biotin mediated 
interaction. Having shown that the microparticles would self-assemble upon 
addition of a critical quantity of avidin, the next stage was to assess potential 
applications. The gel-like properties of the scaffold (G"<G') induced by the 
addition of avidin indicate that complex three-dimensional shapes could be 
formed. Furthermore, the receptor-ligand mediated method of self-assembly 
suggests that cells could be entrapped within the scaffold without harmful 
trigger signals such as UV exposure or temperature changes. 
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6.2 Methods and Materials 
6.2.1 Formation of three-dimensional scaffolds 
A poly(dimethyl siloxane) (PDMS) mould was formed by curing its 
prepolymer (Sylgard 184, Dow Coming) on a defined square based pyramidal 
shape. The PDMS mould was peeled off and washed with ethanol, hexane and 
de-ionized water. A scaffold (30% biotin-PEG-biotin, 60% avidin saturated 
PLA-PEG-biotin microparticles) was then injected into the mould. Following 
crosslinking of the two components of the scaffold, the mould was cut away to 
reveal the scaffold in the pyramidal shape of the mould into which it was 
injected. A further scaffold was manufactured (30% biotin-PEG-biotin, 60% 
PLA-PEG-biotin microparticles) without any avidin. Further PDMS moulds 
were made using a cube and round tablet like shape. Scaffolds in the shapes of 
these moulds were then also prepared with and without avidin. These were then 
assessed by SEM. 
6.2.2 Cell culture experiments 
3T3 fibroblasts (ATCC) and bovine aortic endothelial cells (ECACC) were 
cultured in DMEM supplemented with 10% foetal calf serum, 2 m1Vi L- 
glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin and 0.25 pg/ml 
amphotericin B. Cell cultures were incubated at 37°C in a 5% CO2 enriched 
atmosphere. Approximately 1x 106 of the 3T3 fibroblasts were placed into a 
mixture of 50% PLA-PEG-biotin microparticles and an optimum amount of 
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avidin (2mgs) was added to this to aggregate the microparticles and entrap the 
cells. This same procedure was then completed using 1x 106 bovine aortic 
endothelial cells (BAECs). Scaffolds were then prepared for SEM by fixing the 
cells on the scaffold using lml of a 3% glutaraldehyde in 0.1 M phosphate 
buffer (pH 7.2) and leaving at 4°C overnight. The scaffolds were then washed 
3 times in phosphate buffer for 15 minutes at a time. The fixative was poured 
off and then iml of 1% OS04 solution was added to fix the cells and provide a 
conductive coating of osmium. This improved the final image quality by 
reducing charging under the electron beam and enhancing the secondary 
electron emission. The scaffolds were washed 3 times in distilled water and 
dehydrated through a series of ethanol concentrations. Samples were then gold- 
coated and examined as described previously. 
Human Osteoblast Sarcoma (HOS) cells were cultured in Dulbecco's modified 
Eagle's Medium (DMEM) supplemented with 10% foetal calf serum (FCS), 2 
mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 0.25 gg/ml 
amphotericin B (antibiotic/antimycotic), 1x NEAA and 75 mg ascorbic acid. 
Cell cultures were incubated at 37°C in a 5% CO2 enriched atmosphere. Every 
2-3 days the cells were passaged, using 0.25% trypsin/ 1mM EDTA in PBS, 
and reseeded. Cells were incubated with Cell Tracker green CMFDA (5- 
chloromethylfluorescein diacetate) fluorescent stain (Molecular Probes), by 
reconstituting the material in 11 µl DMSO and adding this solution to the 
media of a confluent monolayer of cells for 45 min. The medium was then 
replaced and the cells incubated for a further hour. Following trypsinization 
and resuspension, the cells were centrifuged and resuspended in DMEM. 
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Approximately 1x 106 cells were placed into a mixture of 50% avidin 
saturated PLA-PEG-biotin microparticles and 25% biotin-PEG-biotin was 
added to this to aggregate the microparticles and entrap the cells. Scaffolds 
were examined using a confocal microscope. 
6.2.3 Injected scaffold stability studies 
Agarose gels were prepared at 0.5,1 and 2% concentrations. Initial studies 
using PLA-PEG microparticles indicated that diffusion of microparticles was 
best achieved using 0.5% Agarose gels. Scaffolds using 25% biotin-PEG- 
biotin, 50% avidin saturated PLA-PEG-biotin microparticles and 1x 106 HOS 
cells were injected (2 ml) into the agarose gels. As a control, 25% biotin-PEG- 
biotin and 50% PLA-PEG-biotin microparticles (without avidin) and 1x 106 
HOS cells were injected (2 ml) into the agarose gels. A further control was to 
inject (2 ml) a scaffold using 25% Biotin-PEG-biotin, 50% avidin saturated 
PLA-PEG-biotin microparticles with no cells. 
6.2.4 The Alamar blue assay for cell viability 
An Alamar blue 10% working solution was prepared by mixing lml of an 
Alamar blue stock solution (Serotec) with 9 ml of Hanks Balanced Salts 
Solution (HBSS) without Phenol Red (Sigma) and sterilised using a 0.2 µm 
filter. The Alamar blue assay was carried out using 1x 106 HOS cells 
entrapped within scaffolds prepared as described previously. Blanks using 
tissue culture plastic, cell free scaffolds and cells alone were carried out as 
comparisons. 100 µl samples were taken from each sample and placed into a 
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96 well plate, which was gently shaken for 5 minutes. Measurements were 
made using a plate reader (Ex 530 nm/Emm 590 nm) with a sensitivity setting 
at 50. 
6.2.5 In vivo studies of polymer and cell composites. 
In vivo studies on the self-assembling scaffold were carried out in conjunction 
with Dr Richard Orrefo of the University of Southampton. 
Defined defects within chicken bones were filled in situ with self-assembled 
scaffolds containing 1* 106 osteoprogenitor cells obtained from a young 
human. These were then placed onto the chorioallantoic membranes of chick 
embryos (CAMs). The CAMs were incubated for a period of up to 7 days 
before sample preparation. A total of 21 CAMs were included in the in vivo 
studies. This comprised of 4 controls without cells and 4 samples with 
additional BMP2 growth factor. The remaining CAMs were then included in 
the studies for repeatability controls. 
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6.3 Results and Discussion 
Having established that PLA-PEG-biotin microparticles would self-assemble 
together upon addition of optimum quantities of avidin, the potential for this 
system as an injectable cell delivery device for tissue engineering was assessed. 
This could be achieved as illustrated schematically in Figure 6.1, by taking a 
mixture of microparticles and crosslinking with avidin as described in Chapter 
5, but this time adding cells to the microparticle suspension thereby entrapping 
the cells within the aggregating particles. The interconnected porous structure 
as characterised in Chapter 5 would then allow the cells to spread and infiltrate 
the rest of the scaffold. 
6.3.1 Formation of three-dimensional scaffolds 
Mechanical testing of scaffolds in Chapter 5 had indicated that the 
microparticle aggregates had gel-like properties. Thus, such a system had 
potential for the formation of complex three-dimensional shapes using mould 
casting. Initially cell free scaffolds were formed. Such scaffolds could be used 
to fill a cavity within a patient and then promote infiltration of cells from 
neighbouring sites via scaffold-loaded signals. Figure 6.2 demonstrates the 
manufacturing process for the scaffold. In this process, avidin saturated PLA- 
PEG-biotin microparticles (60%) are co-injected with biotin-PEG-biotin (30%) 
into a PDMS cast of a defined pyramidal shape. Following crosslinking, the 
PDMS mould was cut away to reveal a porous scaffold that conformed to the 
pyramidal shape of the mould into which it was injected. 
181 
Chapter 6: Three-dimensional porous polymer and cell composites that self-assemble in situ 
a 
Avidin 
A0 
10 
Binding 
Biotn group 
Biotinylated PLA-PEG microparticle 
Figure 6.1 Schematic of the process of the self- assembly of porous polymer 
and cell composites. 
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Microparticles Biotin-PEG-biotin 
PDMS mould cut away to The final scaffold reveal defined three- 
dimensional scaffold 
Figure 6.2 Defined three-dimensional pyramid scaffold fabricated with 
avidin saturated microparticles and biotin-PEG-biotin in PDMS mould 
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The SEM images in Figure 6.3 demonstrate the versatile range of shapes that 
this system can produce. In the absence of the cross-linker, avidin, the 
microparticle slurry fails to maintain the shape on removal from the mould. 
These results are thus consistent with the rheometry data, which showed that 
crosslinking by avidin was necessary for structural and gel like properties. 
6.3.2 Entrapping and delivering cells 
To assess whether such scaffolds could self-assemble to form three- 
dimensional porous polymer and cell composites, a preliminary study of 
aggregation of PLA-PEG-biotin microparticles with cells was carried out using 
fibroblasts and endothelial cells. These were prepared by aggregating 
microparticles under cell culture conditions and assessing their properties 
under SEM. Figure 6.4 illustrated that microparticles would self-assemble 
under these conditions; however, there were clearly a number of limitations in 
the study that needed to be addressed. Firstly, it was difficult to assess after 
SEM sample processing, whether aggregation was because of dehydration 
(necessary for cell fixation) or the crosslinking process. Furthermore, while 
SEM images appear three-dimensional, they preclude quantification of bulk 
interior structure. Whilst fibroblasts with good morphology could be seen with 
microparticles on the fringe of the scaffold aggregates (Figure 6.4), it was 
difficult to assess the entrapped cells within the scaffold. 
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1. Scaffolds with avidin 2. Scaffolds without avidin 
Cross-section of 
scaffolds w/o avidin 
Figure 6.3 The formation of three dimensional structures using PDMS moulds: 
A) Square based pyramid, B) Round Tablet, C) Cube, D) Square based 
pyramid scaffold formed without avidin showing scaffold's failure to maintain 
shape and E/F) Close-up of a cross-section of the scaffold without avidin. 
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Figure 6.4 Preliminary study of aggregation of microparticlcs under cell culture 
condition (DMEM with FCS, ARAM, L-glutamine, 37°C, 3T3 fibroblasts or BAI, ('s). SFM 
samples fixed with glutaraldehyde, coated with OsO4 and dehydrated and then gold coated. 
A/B) Microparticles aggregating under cell culture conditions. C/D) 3T3 
Fibroblasts associating with microparticles on the fringe of scaffold aggregates 
E/F) BAECS on an aggregated microparticle scaffold 
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Finally, in assessing potential applications for the scaffold, it was determined 
that the repair of damaged bone type tissues such as that found in the spinal 
column would be an ideal candidate for delivering cells such as osteoblasts 
within the injectable scaffold, given the delicate nature of surgical procedures 
around this region. For this reason, a pyramidal shaped scaffold with 1x106 
human osteoblast sarcoma (HOS) cells entrapped within the structure was 
formed. 
Confocal microscopy has been demonstrated to be a powerful tool in the 
analysis of three-dimensional porous scaffolds (Tjia and Moghe 1998) and was 
thus used to produce optically sectioned serial 2-D images of human 
osteoblasts entrapped within our self-assembled scaffold. The confocal 
fluorescence images in Figure 6.5 display the distribution of cell populations 
through sections of the scaffold with the cells identified by a fluorescent 
marker (green/excitation 488nm) and the PLA-PEG-biotin microparticles 
identified by the reflected light signal (red/RT 30/70). Confocal images were 
taken throughout the scaffold and displayed single cells and small clusters of 
cells distributed evenly. 
6.3.3 Scaffold formation in simulated tissues 
To demonstrate that the cross-linking process for the formation of a 3D 
scaffold within a simulated tissue was feasible; 0.5% agarose gels were 
prepared and microparticles, biotin-PEG-biotin and cells were injected without 
avidin, through a syringe needle. 
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Figure 6.5 Series of Confocal microscopy images of cross-sections of scaffold 
(red reflectance) displaying entrapped osteoblasts (green, CellTrackerTM). 
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The microparticles were able to diffuse through the agarose and, hence, did not 
form a scaffold (Figure 6.6). Higher concentrations of agarose at 1% and 2% 
were not suitable because microparticles without avidin did not diffuse through 
The experiment was then repeated but this time avidin was co-injected with the 
saturated microparticles. Agarose images in Figure 6.6 display the ability of the 
injected scaffold containing the avidin crosslinking agent with entrapped cells 
to maintain shape in comparison to injected scaffolds without avidin. The 
scaffold structure shown in Figure 6.6 instantly formed as a result of the self- 
assembly process converting the colloidal injection into a solid mass. Such a 
procedure could be used to inject cells into soft tissue sites forming scaffolds 
within a restricted region. 
Scaffolds formed in the simulated tissues were then tested for cell viability 
using the Alamar blue test. The Alamar blue assay incorporates a 
fluorometric/colourimetric growth indicator based on the detection of 
metabolic activity. The system incorporates an oxidation-reduction (RE DOX) 
indicator that both fluoresces and changes colour in response to a chemical 
reduction of growth medium resulting from cell metabolism. As cells grow in 
culture, innate metabolic activity results in a chemical reduction of the 
immediate surrounding environment. Continued viability maintains a reduced 
environment while inhibition of viability maintains an oxidized environment. 
Reduction related to metabolism causes the REDOX indicator to change from 
oxidised (non-fluorescent, blue) to a reduced form (fluorescent, red). 
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Figure 6.6 A) Scaffolds using 25% biotin-PEG-biotin, 50% avidin saturated 
PLA-PEG-biotin microparticles and Ix 106 human osteoblast sarcoma (HOS) 
cells injected (2ml) into 0.5% agarose gels. B) As a control, 25% biotin-PEG- 
biotin, 50% PLA-PEG-biotin microparticles (without avidin) and Ix 106 HOS 
cells were injected (2ml) into 0.5% agarose gels and failed to hold a scaffold 
shape. 
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Cells entrapped within the scaffold, demonstrated viability, with an initial 
fluorescence of 1854 at 30 minutes, increasing to 4563 at the 4-hour time point 
(Figure 6.7). It is worth noting that the period of time over which this assay 
was performed was not enough to elucidate growth statistics. The lack of a 
suitable standard also means that no conclusions other than viability of the cells 
can be drawn from this data. Furthermore, the scaffolds tested were in their 
untreated form and with the use of targeted cell adhesive biotinylated peptides 
and/or appropriate growth factors, cell spreading and viability could be 
increased (Cannizzaro et al. 1998). 
6.3.5 In vivo performance of scaffold/cell composites 
Having shown that cells remained viable within the scaffold, the next stage was 
to assess the scaffold's performance in vivo. Osteoprogenitor cells obtained 
from a young human were used to produce polymer and cell composites within 
bone defects. These were then tested on the chorioallantoic membranes of 
chick embryos over a period of up to 7 days. Whilst this model lacks a full 
immunogenic system, initial results as illustrated in Figure 6.8 indicate that 
bone defects filled with scaffold-cell composites will become vascularized and 
this therefore holds great potential for further development. 
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Figure 6.7 Alamar Blue assay results on entrapped HOS cells (1x106) after 
injection and crosslinking in scaffold. 
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Figure 6.8 In vivo images showing vascularization of bone defects filled with 
self-assembling osteoprogenitor/scaffold composites. A) Top view of bone and 
B) bottom view of bone on the membrane of the chick embryo. (White boxes 
indicate section of bone filled with self-assembling scaffold) 
(Courtesy of R. Oreffo, University of Southampton) 
194 
Chapter 6: Three-dimensional porous polymer and cell composites that self-assemble in situ 
6.4 Conclusion 
The novel molecular-interaction mechanism of self-assembly of these scaffolds 
differentiates this material from other injectable systems. Cell and polymer 
composites can be formed in situ, using an injectable system, without 
transformation via cell harmful trigger signals. Furthermore, scaffolds are 
formed with interconnected porous structures allowing cell infiltration. 
Using PDMS moulds, defined three-dimensional scaffolds were produced. 
These failed to maintain their shape without the addition of avidin. Similarly 
injection of the scaffold in simulated tissues using weak agarose gels showed 
that microparticles would diffuse without avidin but maintained shape with the 
crosslinking agent. 
In vitro studies have demonstrated that cells entrapped within the self- 
assembled scaffolds are well distributed and remain viable. In vivo studies 
using chick embryos were than carried out with osteoprogenitor cells entrapped 
within self-assembled scaffolds. These polymer and cell composites were 
shown to be capable of undergoing vascularization and promoting tissue 
ingrowth. 
Whilst avidin has generated immune responses in vivo; concerns over the long 
term in vivo potential of the self-assembling scaffold due to the antigenicity of 
the avidin molecule are countered by the use of PEG, which reduces immune 
responses to avidin significantly (Marshall and Pedley 1996). 
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This self-assembling material thus has a wide variety of applications from the 
formation of preformed defined three-dimensional scaffolds without the use of 
toxic solvents to the injectable delivery of viable cells within a porous matrix. 
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CONCLUSIONS 
An aim in tissue engineering is to achieve natural regeneration of tissues and 
organs by utilising the natural healing process. Often it is necessary to use a 
scaffold to support tissue growth. This can be with or without cell 
transplantation within the scaffold. Scaffolds without cells could promote cell 
ingrowth and vascularization using controlled release of growth factors in a 
process known as tissue induction. 
The use of scaffolds with cells is necessary because isolated cells injected into 
the body at random cannot form new tissue on their own. Within scaffolds 
however, the cells can begin to secrete their own extracellular matrix, the 
polymer scaffold degrades and is eventually eliminated from the body, 
resulting in completely natural tissue replacement. 
Scaffolds must satisfy a number of requirements for use in cell transplantation. 
They must have cell-interactive surface properties, porosity, biodegradability 
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and suitable mechanical properties. The scaffold should also be ideally capable 
of controlled release. 
To date, research has been focussed on two areas of scaffolds for tissue 
regeneration. These have been water-insoluble porous scaffolds or injectable 
gels. Water-insoluble scaffolds have traditionally been based on synthetic 
biodegradable biomaterials that are established as surgical materials. In 
contrast, research on injectable gels has been directed towards natural 
materials. These natural materials can suffer from a variety of problems 
relating to immunogenicity and lack of mechanical strength. A number of 
synthetic injectable materials have also been developed. However, these 
synthetic materials generally require cell harmful trigger signals for the 
transformation to gel, such as UV exposure, pH changes or sudden temperature 
changes. The most significant difficulty with injectable materials, however, lies 
in the lack of porosity within these gels limiting tissue formation and 
vascularization to the barrier of diffusion of signalling and nutrient molecules. 
Traditional water-insoluble scaffolds have been designed to be porous, 
biodegradable, cell interactive and with tailored mechanical strength. However, 
these materials require invasive surgical procedures and prior knowledge of the 
shape of the defect/cavity. Furthermore, cell seeding can suffer from poor 
transport of the cell through the scaffold. 
The purpose of the work presented in this thesis was to combine the benefits of 
traditional scaffolds with those of the injectable materials. In Chapter 3, the 
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synthesis of a novel biomaterial with self-assembling properties that can 
integrate biological activity into its surface chemistries is described. PLA-PEG- 
biotin combines the benefits of PLA-PEG based copolymer systems with the 
advantages of the universal avidin-biotin linkage system. Using 'H-NMR 
spectroscopic, DSC, GPC, SPR analysis and fluorescent spectroscopy studies, 
the synthesis of PLA-PEG-biotin was shown to maintain the integrity of the 
functionalised end-group without affecting the bulk properties. The synthesis 
thus provides us with a material that can form the foundation of our proposed 
self-assembling porous scaffold. 
As described, the potential for controllable porosity by our proposed self- 
assembling scaffold is a considerable advantage over other injectable in situ 
transforming biomaterials. Therefore before manufacturing the scaffold, a 
comprehensive study of two model cell types involved in vascularization 
processes was carried in out Chapter 4, over a series of defined pore features. 
This study of cells over defined pore features determined that cell behaviour is 
interlinked by three factors: 1) cell type, 2) cell density and 3) pore size. These 
observations were important because the proposed scaffold would be able to 
control pore size and its self-assembling process could control distribution of 
cells throughout the scaffold. Therefore the next stage was to manufacture and 
conduct a systematic physico-chemical study on the potential of the self- 
assembling porous scaffold. 
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In Chapter 5, using a single emulsion method, microparticles were 
manufactured with the PLA-PEG-biotin synthesised in Chapter 3. SPR analysis 
demonstrated that the microparticles would bind with avidin. Aggregation 
studies revealed that by using precise concentrations of avidin, a cross-linking 
of the microparticles occurs and a scaffold forms. Above and below these 
concentrations, optimal aggregation is prevented through insufficient binding 
sites or saturation of the binding sites. Tailoring the individual components of 
the scaffold was shown to control the mechanical properties. Where increased 
load bearing properties were necessary, bi-functional PEG could be added to 
increase the gel-forming component in the scaffold. To demonstrate the 
possibility of controllable properties such as porosity, the scaffold formation 
was carried out using both nano and microparticles. 
Next, potential applications of this self-assembling scaffold were assessed. In 
Chapter 6, the use of the self-assembling process in cell delivery and in 
forming defined three-dimensional scaffolds was investigated. Using simulated 
environments, the scaffold was able to form defined three-dimensional shapes 
within defined cavities or soft-tissues. Polymer and cell composites were 
formed using human osteoblast sarcoma cells. The Alamar blue assay 
confirmed these cells remained viable once seeded within the scaffold. In vivo 
studies were then carried out with chick embryos using human osteoprogenitor 
cells entrapped within the self-assembling scaffolds. These studies showed that 
such polymer and cell composites were capable of tissue ingrowth and would 
therefore readily undergo vascularization. 
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The novel scaffold presented in this thesis combines the benefits of both 
traditional water-insoluble scaffolds and injectable biomaterials. The novel 
self-assembling process produces a scaffold that can form in situ using a 
binding mechanism that does not interfere with cells. Thus the scaffold is 
capable of highly efficient well-distributed cell seeding. The interconnected 
porous structure of the scaffold once formed allows cell infiltration and thus 
vascularization. The basic component of the scaffold is a biodegradable 
microparticle that can be formed from any of the poly (a-hydroxyacids) or 
indeed other polymers. Hence, conventional controlled release technologies 
and surface engineering can be combined with the self-assembly to form 
biomimetic scaffolds that stimulate integrin-mediated cell adhesion and then 
release growth factors. The ability of the scaffold to form a versatile range of 
shapes in situ with porous morphology and favourable rheological properties 
thus has potential for a variety of tissue engineering and drug delivery 
applications. 
7.1 Further work. 
The numerous advantages presented by the scaffold include the use of 
controlled release of growth factors from the microparticles and surface 
engineering of the scaffolds through cell adhesive peptides. Therefore future 
work may include studies that combine these modifications with the scaffold. 
The potential for the scaffold to self-assemble in vivo is in part dependent on 
the delivery vehicle. Therefore the development of a syringe system that can 
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deliver both the crosslinking factor and the cells and/or microparticles is a 
further area of investigation. 
Finally, the potential for microparticles to aggregate is not restricted to the 
avidin-biotin interaction. Therefore, given the possible immunogenic responses 
to the avidin within the scaffold, it is a desirable strategy to search for 
alternative crosslinking processes. For example, microparticles manufactured 
from a positively charged polymer could potentially aggregate upon addition of 
negatively charged ions. 
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